{
  "symbol": "MRK",
  "frequency": "quarterly",
  "timestamp": "2025-09-19T15:41:48.227752",
  "data": {
    "cik": "310158",
    "data": [
      {
        "accessNumber": "0000310158-25-000014",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2025,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2025-01-01 00:00:00",
        "endDate": "2025-06-30 00:00:00",
        "filedDate": "2025-08-05 00:00:00",
        "acceptedDate": "2025-08-05 16:13:52",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8007000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 615000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $94 in 2025 and $89 in 2024)",
              "value": 11846000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $4,882 in 2025 and $4,193 in 2024 classified in Other assets - see Note\u00a06)",
              "value": 6601000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 9996000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 37065000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 774000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $20,256 in 2025 and $19,155 in 2024",
              "value": 25236000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21591000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 15193000000
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 17664000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 117523000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 1434000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3892000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 14502000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 4156000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 2053000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 26037000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 33968000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1427000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7031000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2025 and 2024",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44644000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 68477000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5421000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 109488000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,073,963,194 shares in 2025 and 1,049,466,187 shares in 2024",
              "value": 60495000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 48993000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 67000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 49060000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 117523000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 31335000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 6976000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 5202000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 7669000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 629000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 43000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 20433000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 10902000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 1388000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 9514000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 8000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 9506000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 3.78
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 3.77
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -627000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net loss and prior service cost, net of amortization",
              "value": 26000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 177000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -476000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 9030000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 9514000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1198000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1020000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Income from investments in equity securities, net",
              "value": 189000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for research and development asset acquisition",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -634000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 411000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -444000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 5971000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 5793000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 2092000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 1207000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1057000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Harpoon Therapeutics, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 15000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -2257000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 48000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2500000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 4127000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 2509000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 31000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -254000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -9311000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 530000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -5245000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-25-021834",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2025,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2025-01-01 00:00:00",
        "endDate": "2025-03-31 00:00:00",
        "filedDate": "2025-05-02 00:00:00",
        "acceptedDate": "2025-05-02 16:10:22",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8629000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 599000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $93 in 2025 and $89 in 2024)",
              "value": 10790000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $4,556 in 2025 and $4,193 in 2024 classified in Other assets - see Note\u00a06)",
              "value": 6196000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 9289000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 35503000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 616000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $19,680 in 2025 and $19,155 in 2024",
              "value": 24793000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21684000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 15758000000
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 16768000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 115122000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 1360000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3784000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 12772000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 5181000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 2077000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 25174000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 33484000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1409000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 6655000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2025 and 2024",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44816000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 66097000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4965000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 107736000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,061,021,894 shares in 2025 and 1,049,466,187 shares in 2024",
              "value": 59401000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 48335000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 65000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 48400000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 115122000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 15529000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 3419000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 2552000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 3621000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 69000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 35000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 9626000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 5903000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 818000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 5085000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 6000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 5079000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.01
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.01
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -217000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 18000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 215000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -20000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 5059000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 5085000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 597000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 502000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Income from investments in equity securities, net",
              "value": 90000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for research and development asset acquisition",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -186000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 195000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -109000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 3712000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 2500000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1328000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 595000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 456000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Harpoon Therapeutics, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 20000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -1487000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2500000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2050000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1164000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 19000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -60000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -5755000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 156000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Decrease in Cash, Cash Equivalents and Restricted Cash",
              "value": -4586000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-24-045689",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2024,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2024-01-01 00:00:00",
        "endDate": "2024-09-30 00:00:00",
        "filedDate": "2024-11-06 00:00:00",
        "acceptedDate": "2024-11-06 16:05:36",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 14593000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $79 in 2024 and $88 in 2023)",
              "value": 11381000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $3,995 in 2024 and $3,348 in 2023 classified in Other assets - see Note\u00a06)",
              "value": 6244000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 8143000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 40361000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 575000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $19,072 in 2024 and $18,266 in 2023",
              "value": 23446000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21697000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 17010000000
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 14443000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 117532000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3149000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3586000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 16539000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 4330000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1982000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 29586000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 34982000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 864000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7540000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2024 and 2023",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44530000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 61384000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5371000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 102331000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,045,073,377 shares in 2024 and 1,045,470,249 shares in 2023",
              "value": 57829000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 44502000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 58000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 44560000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 117532000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 48544000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 11365000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 7952000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 13354000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 258000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 151000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 32778000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 15766000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 2377000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 13389000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 15000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 13374000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 5.28
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 5.26
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -99000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 28000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -83000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -210000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 13164000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 13389000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1720000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1582000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Income from investments in equity securities, net",
              "value": 169000000.0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationOrJointVentureFormationWriteoffAssetAcquisitionFour",
              "unit": "usd",
              "label": "Charge for the acquisition of Eyebiotech Limited",
              "value": 1350000000
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationOrJointVentureFormationWriteoffAssetAcquisitionFive",
              "unit": "usd",
              "label": "Charge for the acquisition of MK-1045 (formerly CN201) from Curon Pharmaceutical",
              "value": 750000000
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationOrJointVentureFormationWriteoffAssetAcquisitionTwo",
              "unit": "usd",
              "label": "Charge for the acquisition of Harpoon Therapeutics, Inc.",
              "value": 656000000
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationOrJointVentureFormationWriteoffAssetAcquisitionThree",
              "unit": "usd",
              "label": "Charge for the acquisition of Prometheus Biosciences, Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Imago BioSciences, Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -633000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 574000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -611000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 1812000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 18018000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 2435000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 64000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 370000000
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFiveNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Eyebiotech Limited, net of cash acquired",
              "value": 1344000000
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFour",
              "unit": "usd",
              "label": "Acquisition of Elanco Animal Health Incorporated aqua business",
              "value": 1301000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Harpoon Therapeutics, Inc., net of cash acquired",
              "value": 746000000
            },
            {
              "concept": "mrk_PaymentsToAcquireGlobalRights",
              "unit": "usd",
              "label": "Acquisition of MK-1045 (formerly CN201) from Curon Pharmaceutical",
              "value": 700000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Prometheus Biosciences, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Imago BioSciences, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 70000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -6290000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 3599000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 751000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5889000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 817000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 165000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -330000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -4023000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 74000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 7779000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-24-034715",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2024,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2024-01-01 00:00:00",
        "endDate": "2024-06-30 00:00:00",
        "filedDate": "2024-08-05 00:00:00",
        "acceptedDate": "2024-08-05 16:02:11",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 11304000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 50000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $82 in 2024 and $88 in 2023)",
              "value": 11642000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $3,456 in 2024 and $3,348 in 2023 classified in Other assets - see Note\u00a06)",
              "value": 6469000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 8740000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 38205000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 357000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,960 in 2024 and $18,266 in 2023",
              "value": 23221000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21161000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 16984000000
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 12702000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 112630000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3071000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3519000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 14712000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 2777000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1981000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 26060000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 34717000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 876000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7329000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2024 and 2023",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44362000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 60187000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5361000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 100976000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,041,454,052 shares in 2024 and 1,045,470,249 shares in 2023",
              "value": 57394000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 43582000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 66000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 43648000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 112630000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 31887000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 7285000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 5221000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 7492000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 202000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -12000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 20212000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income (Loss) Before Taxes",
              "value": 11675000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income Tax Provision",
              "value": 1447000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income (Loss)",
              "value": 10228000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 11000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income (Loss) Attributable to Merck & Co., Inc.",
              "value": 10217000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings (Loss) per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 4.03
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings (Loss) per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 4.02
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain on derivatives, net of reclassifications",
              "value": 197000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 15000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -382000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -200000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income (Loss) Attributable to Merck\u00a0& Co., Inc.",
              "value": 10017000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income (Loss)",
              "value": 10228000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1087000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1029000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Income from investments in equity securities, net",
              "value": 200000000.0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationOrJointVentureFormationWriteoffAssetAcquisitionTwo",
              "unit": "usd",
              "label": "Charge for the acquisition of Harpoon Therapeutics, Inc.",
              "value": 656000000
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationOrJointVentureFormationWriteoffAssetAcquisitionThree",
              "unit": "usd",
              "label": "Charge for the acquisition of Prometheus Biosciences, Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Imago BioSciences, Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -232000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 379000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -174000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 4394000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 8727000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1652000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 64000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 320000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Harpoon Therapeutics, Inc., net of cash acquired",
              "value": 746000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Prometheus Biosciences, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Imago BioSciences, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 303000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -2445000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 3600000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 751000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3936000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 373000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 160000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -298000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities",
              "value": -1598000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -220000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 4464000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-24-020283",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2024,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2024-01-01 00:00:00",
        "endDate": "2024-03-31 00:00:00",
        "filedDate": "2024-05-03 00:00:00",
        "acceptedDate": "2024-05-03 16:10:43",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 5579000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 40000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $80 in 2024 and $88 in 2023)",
              "value": 11366000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $3,413 in 2024 and $3,348 in 2023 classified in Other assets - see Note\u00a06)",
              "value": 6510000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 7950000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 31445000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 280000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,620 in 2024 and $18,266 in 2023",
              "value": 23045000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21181000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 17572000000
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 12326000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 105849000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3077000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3514000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 14102000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 2398000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 2008000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 25099000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 31142000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 922000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8262000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2024 and 2023",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44598000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 56697000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5274000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 97809000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,044,402,655 shares in 2024 and 1,045,470,249 shares in 2023",
              "value": 57445000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 40364000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 60000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 40424000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 105849000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 15775000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 3540000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 2483000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 3992000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 123000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 33000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 10105000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 5670000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 903000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 4767000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 5000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 4762000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1.88
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1.87
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 130000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 5000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -238000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -113000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 4649000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 4767000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 473000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 511000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Income from investments in equity securities, net",
              "value": 143000000.0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAssetAcquisitionTwo",
              "unit": "usd",
              "label": "Charge for the acquisition of Harpoon Therapeutics, Inc.",
              "value": 656000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Imago BioSciences, Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -51000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 176000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -83000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 3382000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 3090000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 861000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 15000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 260000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Harpoon Therapeutics, Inc., net of cash acquired",
              "value": 746000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Imago BioSciences, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 14000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -1376000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 751000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1950000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 122000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 87000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -78000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -2814000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -138000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Decrease in Cash, Cash Equivalents and Restricted Cash",
              "value": -1238000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-23-036717",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2023,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2023-01-01 00:00:00",
        "endDate": "2023-09-30 00:00:00",
        "filedDate": "2023-11-03 00:00:00",
        "acceptedDate": "2023-11-03 16:10:43",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8605000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 168000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $85 in 2023 and $72 in 2022)",
              "value": 10394000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $3,151 in 2023 and $2,938 in 2022 classified in Other assets - see Note\u00a07)",
              "value": 6131000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 6656000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 31954000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 1306000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,446 in 2023 and $17,985 in 2022",
              "value": 22526000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21183000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 19199000000
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 10559000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 106727000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 887000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3509000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 14840000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1981000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1877000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 23094000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 33972000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1018000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7343000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44358000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 57082000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4916000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 98312000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,041,809,729 shares in 2023 and 1,039,269,638 shares in 2022",
              "value": 57066000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 41246000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 54000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 41300000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 106727000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 45485000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 12214000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 7700000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 20904000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 344000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -388000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 41550000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 3935000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 2332000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1603000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 12000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 1591000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 0.63
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 0.62
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain on derivatives, net of reclassifications",
              "value": 171000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 75000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -244000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -148000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 1443000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1603000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1582000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1326000000
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 13000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "(Income) loss from investments in equity securities, net",
              "value": 240000000.0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquisitionOtherThanThroughBusinessCombinationWriteOffAssetAcquisitionTwo",
              "unit": "usd",
              "label": "Charge for the acquisition of Prometheus Biosciences, Inc.",
              "value": 10217000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Imago BioSciences, Inc.",
              "value": 1192000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -968000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 478000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 94000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2349000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 12760000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 2874000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 704000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1489000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Prometheus Biosciences, Inc., net of cash acquired",
              "value": 10705000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Imago BioSciences, Inc., net of cash acquired",
              "value": 1327000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 15000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -14136000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 5939000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1752000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 953000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5593000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 119000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -325000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -2565000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -163000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -4104000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-23-027770",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2023,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2023-01-01 00:00:00",
        "endDate": "2023-06-30 00:00:00",
        "filedDate": "2023-08-07 00:00:00",
        "acceptedDate": "2023-08-07 16:09:00",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 5660000000
            },
            {
              "concept": "us-gaap_ShortTermInvestments",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 718000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $86 in 2023 and $72 in 2022)",
              "value": 11030000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $3,220 in 2023 and $2,938 in 2022 classified in Other assets - see Note\u00a07)",
              "value": 5930000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 6639000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 29977000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 1214000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,432 in 2023 and $17,985 in 2022",
              "value": 22231000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21195000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 19665000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 10187000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 104469000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2839000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3442000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 13747000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1489000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1877000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 23394000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 34072000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 996000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7265000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44219000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 54198000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4900000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 95305000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,037,678,033 shares in 2023 and 1,039,269,638 shares in 2022",
              "value": 56612000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 38693000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 49000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 38742000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 104469000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 29522000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 7951000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 5182000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 17597000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 218000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -259000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 31207000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "(Loss) Income Before Taxes",
              "value": -1685000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income Tax Provision",
              "value": 1500000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net (Loss) Income",
              "value": -3147000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 7000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net (Loss) Income Attributable to Merck & Co., Inc.",
              "value": -3154000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic (Loss) Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": -1.24
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "(Loss) Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": -1.24
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain on derivatives, net of reclassifications",
              "value": 12000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 75000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -69000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -132000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive (Loss) Income Attributable to Merck\u00a0& Co., Inc.",
              "value": -3286000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net (loss) income",
              "value": -3147000000
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1020000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 874000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "(Income) loss from investments in equity securities, net",
              "value": 274000000.0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquisitionOtherThanThroughBusinessCombinationWriteOffAssetAcquisitionTwo",
              "unit": "usd",
              "label": "Charge for the acquisition of Prometheus Biosciences, Inc.",
              "value": 10217000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Imago BioSciences, Inc.",
              "value": 1192000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -632000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 314000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -5000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 4526000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 5043000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1972000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 587000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 785000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Prometheus Biosciences, Inc., net of cash acquired",
              "value": 10705000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Imago BioSciences, Inc., net of cash acquired",
              "value": 1327000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -4000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -13802000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 1937000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 5946000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1751000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 487000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3738000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 112000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -315000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Financing Activities",
              "value": 1704000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -6000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -7061000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-23-015990",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2023,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2023-01-01 00:00:00",
        "endDate": "2023-03-31 00:00:00",
        "filedDate": "2023-05-05 00:00:00",
        "acceptedDate": "2023-05-05 07:39:41",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 9707000000
            },
            {
              "concept": "us-gaap_ShortTermInvestments",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 680000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $76 in 2023 and $72 in 2022)",
              "value": 10415000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $3,284 in 2023 and $2,938 in 2022 classified in Other assets - see Note\u00a07)",
              "value": 5863000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 6737000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 33402000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 1290000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,256 in 2023 and $17,985 in 2022",
              "value": 21758000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21209000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 19857000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 10280000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 107796000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2672000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3680000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 13000000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1872000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1907000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 23131000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 28074000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1442000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8244000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44467000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 62039000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4883000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 103411000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,039,651,210 shares in 2023 and 1,039,269,638 shares in 2022",
              "value": 56577000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 46834000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 71000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 46905000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 107796000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 14487000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 3926000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 2479000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 4276000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 67000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -89000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 10837000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 3650000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 825000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 2825000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income (Loss) Attributable to Noncontrolling Interests",
              "value": 4000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 2821000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings Per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1.11
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1.11
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -133000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 50000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 68000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -115000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 2706000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income",
              "value": 2825000000
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 543000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 448000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "(Income) loss from investments in equity securities, net",
              "value": 450000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Imago BioSciences, Inc.",
              "value": 1192000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -277000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 145000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 197000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2890000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 1339000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1007000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 562000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 500000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Imago BioSciences, Inc., net of cash acquired",
              "value": 1327000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -37000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -2359000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 149000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1853000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 30000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -81000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -2054000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 87000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -2987000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-22-000034",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2022,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2022-01-01 00:00:00",
        "endDate": "2022-09-30 00:00:00",
        "filedDate": "2022-11-03 00:00:00",
        "acceptedDate": "2022-11-03 16:28:44",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 11145000000
            },
            {
              "concept": "us-gaap_ShortTermInvestments",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 103000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $77 in 2022 and $62 in 2021)",
              "value": 9482000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,641 in 2022 and $2,194 in 2021 classified in Other assets - see Note\u00a07)",
              "value": 5614000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 7217000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 33561000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 984000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,921 in 2022 and $18,192 in 2021",
              "value": 20424000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21160000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 21368000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 9584000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 107081000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 1936000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3371000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 14222000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1698000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1771000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 22998000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 28482000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 2417000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8660000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44243000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 59928000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4743000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 101216000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,043,697,097 shares in 2022 and 1,049,499,023 shares in 2021",
              "value": 56758000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 44458000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 66000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 44524000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 107081000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 45453000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 13530000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 7355000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 9773000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 288000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -1576000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 32522000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income from Continuing Operations Before Taxes",
              "value": 12931000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income from Continuing Operations",
              "value": 1423000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 11508000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 6000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperations",
              "unit": "usd",
              "label": "Net Income from Continuing Operations Attributable to Merck\u00a0& Co., Inc.",
              "value": 11502000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
              "unit": "usd",
              "label": "Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests",
              "value": 0.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 11502000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 4.55
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 4.55
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 4.53
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 4.53
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain on derivatives, net of reclassifications",
              "value": 584000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": -92000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -990000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -314000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 11188000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 11508000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1623000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1394000000
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 910000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Loss (income) from investments in equity securities, net",
              "value": -1361000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Pandion Therapeutics, Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -1261000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 396000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -1169000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2435000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities of Continuing Operations",
              "value": 14665000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 3239000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 710000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 709000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Pandion Therapeutics, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 121000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -149000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities of Continuing Operations",
              "value": -3212000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2250000000
            },
            {
              "concept": "mrk_DisposalGroupInclDiscontinuedOperationsDistributionReceived",
              "unit": "usd",
              "label": "Distribution from Organon & Co.",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5262000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 119000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -172000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities of Continuing Operations",
              "value": -7565000000
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash provided by operating activities",
              "value": 0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in investing activities",
              "value": 0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in financing activities",
              "value": 0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
              "unit": "usd",
              "label": "Net Cash Flows Provided by Discontinued Operations",
              "value": 0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -776000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": 3112000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-22-000030",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2022,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2022-01-01 00:00:00",
        "endDate": "2022-06-30 00:00:00",
        "filedDate": "2022-08-05 00:00:00",
        "acceptedDate": "2022-08-04 17:35:47",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 9675000000.0
            },
            {
              "concept": "us-gaap_ShortTermInvestments",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 453000000.0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $82 in 2022 and $62 in 2021)",
              "value": 9643000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,764 in 2022 and $2,194 in 2021 classified in Other assets - see Note\u00a07)",
              "value": 5535000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 6810000000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 32116000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 238000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,798 in 2022 and $18,192 in 2021",
              "value": 20059000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21213000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 22497000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 10972000000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 107095000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2979000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3482000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 13501000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1438000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1768000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 23168000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 28684000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 2974000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8951000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44115000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 58437000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4327000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 100013000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,043,894,068 shares in 2022 and 1,049,499,023 shares in 2021",
              "value": 56770000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 43243000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 75000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 43318000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 107095000000.0
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 30494000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 9596000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 4834000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 5374000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 194000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -1148000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 21146000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income from Continuing Operations Before Taxes",
              "value": 9348000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income from Continuing Operations",
              "value": 1092000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 8256000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 2000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperations",
              "unit": "usd",
              "label": "Net Income from Continuing Operations Attributable to Merck\u00a0& Co., Inc.",
              "value": 8254000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
              "unit": "usd",
              "label": "Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests",
              "value": 0.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 8254000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 3.26
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 3.26
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 3.25
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 3.25
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain on derivatives, net of reclassifications",
              "value": 246000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -278000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -422000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 102000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 8356000000.0
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 8256000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1163000000.0
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 895000000.0
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 23000000.0
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Loss (income) from investments in equity securities, net",
              "value": -991000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Pandion Therapeutics, Inc.",
              "value": 0.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -600000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 257000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -776000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2698000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities of Continuing Operations",
              "value": 9063000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 2113000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 705000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 374000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Pandion Therapeutics, Inc., net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -194000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities of Continuing Operations",
              "value": -2250000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 0.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1250000000.0
            },
            {
              "concept": "mrk_DisposalGroupInclDiscontinuedOperationsDistributionReceived",
              "unit": "usd",
              "label": "Distribution from Organon & Co.",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3515000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 109000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -207000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities of Continuing Operations",
              "value": -4863000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash provided by operating activities",
              "value": 0.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in investing activities",
              "value": 0.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in financing activities",
              "value": 0.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
              "unit": "usd",
              "label": "Net Cash Flows Provided by Discontinued Operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -364000000.0
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": 1586000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-22-000011",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2022,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2022-01-01 00:00:00",
        "endDate": "2022-03-31 00:00:00",
        "filedDate": "2022-05-05 00:00:00",
        "acceptedDate": "2022-05-05 16:28:37",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8556000000.0
            },
            {
              "concept": "us-gaap_ShortTermInvestments",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 372000000.0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $95 in 2022 and $62 in 2021)",
              "value": 9828000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,495 in 2022 and $2,194 in 2021 classified in Other assets - see Note\u00a07)",
              "value": 5774000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 6654000000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 31184000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 316000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,498 in 2022 and $18,192 in 2021",
              "value": 19747000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21258000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 23022000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 11141000000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 106668000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 1208000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3715000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 14051000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1571000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1771000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 22316000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 30586000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 3071000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 9742000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44275000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 56252000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4369000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 97946000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,048,727,225 shares in 2022 and 1,049,499,023 shares in 2021",
              "value": 57063000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 40883000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 70000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 40953000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 106668000000.0
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 15901000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 5380000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 2323000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 2576000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 53000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -708000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 11040000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income from Continuing Operations Before Taxes",
              "value": 4861000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income from Continuing Operations",
              "value": 554000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 4307000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net (Loss) Income Attributable to Noncontrolling Interests",
              "value": -3000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperations",
              "unit": "usd",
              "label": "Net Income from Continuing Operations Attributable to Merck\u00a0& Co., Inc.",
              "value": 4310000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
              "unit": "usd",
              "label": "Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests",
              "value": 0.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 4310000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 1.7
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 1.7
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 1.7
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 1.7
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain on derivatives, net of reclassifications",
              "value": 63000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -32000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -35000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 60000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 4370000000.0
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 4307000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 699000000.0
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 421000000.0
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Loss (income) from investments in equity securities, net",
              "value": -708000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -338000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 120000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -143000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 1299000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities of Continuing Operations",
              "value": 4761000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 984000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 372000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -182000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities of Continuing Operations",
              "value": -1173000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 0.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1250000000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1745000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 12000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -103000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities of Continuing Operations",
              "value": -3086000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash provided by operating activities",
              "value": 0.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in investing activities",
              "value": 0.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
              "unit": "usd",
              "label": "Net Cash Flows Provided by Discontinued Operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -55000000.0
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 447000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-21-000032",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2021,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2021-01-01 00:00:00",
        "endDate": "2021-09-30 00:00:00",
        "filedDate": "2021-11-05 00:00:00",
        "acceptedDate": "2021-11-05 16:09:58",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 10016000000.0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $69 in 2021 and $67 in 2020)",
              "value": 8571000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,373 in 2021 and $2,070 in 2020 classified in Other assets - see Note\u00a07)",
              "value": 5603000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 6868000000.0
            },
            {
              "concept": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Current assets of discontinued operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 31058000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 435000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,155 in 2021 and $18,162 in 2020",
              "value": 18565000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18862000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 13384000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 11190000000.0
            },
            {
              "concept": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
              "unit": "usd",
              "label": "Noncurrent Assets of Discontinued Operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 93494000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3534000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3366000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 14214000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 954000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1660000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Current liabilities of discontinued operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 23728000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 22907000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1527000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 9469000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
              "unit": "usd",
              "label": "Noncurrent Liabilities of Discontinued Operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2021 and 2020",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44149000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 51691000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4590000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 93038000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,051,780,149 shares in 2021 and 1,046,877,695 shares in 2020",
              "value": 57244000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 35794000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 69000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 35863000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 93494000000.0
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 35183000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 9752000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 6804000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 9177000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 487000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 1007000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 25213000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income from Continuing Operations Before Taxes",
              "value": 9970000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income from Continuing Operations",
              "value": 1436000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 8534000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 9000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperations",
              "unit": "usd",
              "label": "Net Income from Continuing Operations Attributable to Merck\u00a0& Co., Inc.",
              "value": 8525000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
              "unit": "usd",
              "label": "Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests",
              "value": 766000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co. Inc.",
              "value": 9291000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 3.37
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.3
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 3.67
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 3.36
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.3
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 3.66
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 324000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized loss on investments, net of reclassifications",
              "value": 0.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -1522000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -251000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 1595000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 10886000000.0
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 8534000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1231000000.0
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1148000000.0
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Income from investments in equity securities, net",
              "value": 1535000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentInProcess",
              "unit": "usd",
              "label": "Charge for the acquisition of Pandion Therapeutics, Inc.",
              "value": 1556000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 28000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 360000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -499000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 3794000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities from Continuing Operations",
              "value": 8027000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 3240000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 1000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 497000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Pandion Therapeutics, Inc. net of cash acquired",
              "value": 1554000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 89000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -15000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities from Continuing Operations",
              "value": -4372000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -3983000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1153000000.0
            },
            {
              "concept": "mrk_DisposalGroupIncludingDiscontinuedOperationsDistributionReceived",
              "unit": "usd",
              "label": "Distribution from Organon & Co.",
              "value": 9000000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 822000000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 4967000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 68000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -253000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities from Continuing Operations",
              "value": -2110000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash provided by operating activities",
              "value": 1051000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in investing activities",
              "value": -134000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in financing activities",
              "value": -504000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
              "unit": "usd",
              "label": "Net Cash Flows Provided by Discontinued Operations",
              "value": 413000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -65000000.0
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 1893000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-21-000028",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2021,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2021-01-01 00:00:00",
        "endDate": "2021-06-30 00:00:00",
        "filedDate": "2021-08-09 00:00:00",
        "acceptedDate": "2021-08-09 07:07:53",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8575000000.0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $72 in 2021 and $67 in 2020)",
              "value": 7843000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,412 in 2021 and $2,070 in 2020 classified in Other assets - see Note\u00a07)",
              "value": 5499000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 6748000000.0
            },
            {
              "concept": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Current assets of discontinued operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 28665000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 411000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,236 in 2021 and $18,162 in 2020",
              "value": 18064000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18873000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 13622000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 11053000000.0
            },
            {
              "concept": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
              "unit": "usd",
              "label": "Noncurrent Assets of Discontinued Operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 90688000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2488000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3897000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 12888000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 971000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1662000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Current liabilities of discontinued operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 21906000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 24033000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1489000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 9872000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
              "unit": "usd",
              "label": "Noncurrent Liabilities of Discontinued Operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2021 and 2020",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44039000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 48777000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4628000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 89976000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,044,351,147 shares in 2021 and 1,046,877,695 shares in 2020",
              "value": 56682000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 33294000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 94000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 33388000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 90688000000.0
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 22029000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 6303000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 4468000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 6732000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 380000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 558000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 17325000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income from Continuing Operations Before Taxes",
              "value": 4704000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income from Continuing Operations",
              "value": 741000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 3963000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income (Loss) Attributable to Noncontrolling Interests",
              "value": 5000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperations",
              "unit": "usd",
              "label": "Net Income from Continuing Operations Attributable to Merck\u00a0& Co., Inc.",
              "value": 3958000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
              "unit": "usd",
              "label": "Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests",
              "value": 766000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co. Inc.",
              "value": 4724000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations",
              "value": 1.56
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations",
              "value": 0.3
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Net Income",
              "value": 1.87
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations",
              "value": 1.56
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations",
              "value": 0.3
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Net Income",
              "value": 1.86
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 240000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized loss on investments, net of reclassifications",
              "value": 0.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -1484000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -167000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 1557000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 6281000000.0
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 3963000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 871000000.0
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 749000000.0
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 0.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentInProcess",
              "unit": "usd",
              "label": "Charge for the acquisition of Pandion Therapeutics, Inc.",
              "value": 1556000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 29000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 243000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 526000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 3655000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities from Continuing Operations",
              "value": 3230000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 2068000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 1000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 386000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Pandion Therapeutics, Inc. net of cash acquired",
              "value": 1554000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 90000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -16000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities from Continuing Operations",
              "value": -3311000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -3983000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1153000000.0
            },
            {
              "concept": "mrk_DisposalGroupIncludingDiscontinuedOperationsDistributionReceived",
              "unit": "usd",
              "label": "Distribution from Organon & Co.",
              "value": 9000000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 239000000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3318000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 51000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -194000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Financing Activities from Continuing Operations",
              "value": 164000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash provided by operating activities",
              "value": 1051000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in investing activities",
              "value": -134000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in financing activities",
              "value": -504000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
              "unit": "usd",
              "label": "Net Cash Flows Provided by Discontinued Operations",
              "value": 413000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -19000000.0
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": 477000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-21-000009",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2021,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2021-01-01 00:00:00",
        "endDate": "2021-03-31 00:00:00",
        "filedDate": "2021-05-05 00:00:00",
        "acceptedDate": "2021-05-05 16:26:12",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 6981000000.0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $78 in 2021 and $85 in 2020)",
              "value": 8235000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,175 in 2021 and $2,197 in 2020 classified in Other assets - see Note\u00a06)",
              "value": 6402000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 5291000000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 26909000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 544000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,732 in 2021 and $18,982 in 2020",
              "value": 18295000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 20212000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 14401000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 10486000000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 90847000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 7251000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 4034000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 11911000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1490000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1675000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 26361000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 24002000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1204000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 12241000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2021 and 2020",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39613000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 48888000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -6622000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 83667000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,045,799,775 shares in 2021 and 1,046,877,695 shares in 2020",
              "value": 56722000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 26945000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 94000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 27039000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 90847000000.0
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 12080000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 3670000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 2633000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 2465000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 298000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 448000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 8618000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 3462000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 276000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 3186000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 7000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 3179000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck\u00a0& Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1.26
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck\u00a0& Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1.25
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain on derivatives, net of reclassifications",
              "value": 230000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized loss on investments, net of reclassifications",
              "value": 0.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -81000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -299000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 12000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 3191000000.0
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 3186000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 534000000.0
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 396000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -10000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 120000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 331000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2104000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 1791000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1134000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 1000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 386000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 14000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -25000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -738000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 788000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1153000000.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1645000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 9000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -97000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -2098000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -97000000.0
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Decrease in Cash, Cash Equivalents and Restricted Cash",
              "value": -1142000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-20-000030",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2020,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2020-01-01 00:00:00",
        "endDate": "2020-09-30 00:00:00",
        "filedDate": "2020-11-05 00:00:00",
        "acceptedDate": "2020-11-05 16:55:58",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 7356000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $89 in 2020 and $86 in 2019)",
              "value": 8422000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,081 in 2020 and $1,480 in 2019 classified in Other assets - see Note\u00a06)",
              "value": 6128000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4671000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 26577000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 1372000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,572 in 2020 and $17,686 in 2019",
              "value": 16919000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 20248000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 16677000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 8007000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 89800000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2420000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3744000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 11690000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 984000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1567000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 20405000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 26321000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1777000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 12027000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2020 and 2019",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39489000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 51107000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -6383000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 86001000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,047,343,390 shares in 2020 and 1,038,087,496 shares in 2019",
              "value": 56815000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 29186000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 84000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 29270000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 89800000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 35479000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 9952000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 7383000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 7721000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 269000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 630000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 24695000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 10784000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 1611000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 9173000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income (Loss) Attributable to Noncontrolling Interests",
              "value": 12000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 9161000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck\u00a0& Co., Inc. Common Shareholders (in dollars per share)",
              "value": 3.62
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck\u00a0& Co., Inc. Common Shareholders (in dollars per share)",
              "value": 3.61
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -153000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -18000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -161000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -180000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -190000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 8971000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 9173000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 2721000000
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 35000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentInProcess",
              "unit": "usd",
              "label": "Charge for acquisition of Peloton Therapeutics, Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 47000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 354000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 445000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 5638000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 6247000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 3170000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 78000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1894000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 2545000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Antelliq Corporation, net of cash acquired",
              "value": 0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFourNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Peloton Therapeutics, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 907000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -141000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -4665000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -311000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1954000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 4419000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1281000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 4673000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 68000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -472000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -4204000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 89000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Decrease in Cash, Cash Equivalents and Restricted Cash",
              "value": -2533000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-20-000026",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2020,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2020-01-01 00:00:00",
        "endDate": "2020-06-30 00:00:00",
        "filedDate": "2020-08-05 00:00:00",
        "acceptedDate": "2020-08-05 08:10:57",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 11103000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $90 in 2020 and $86 in 2019)",
              "value": 7577000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 6056000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4607000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 29343000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 1251000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,182 in 2020 and $17,686 in 2019",
              "value": 15789000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 20067000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 16566000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 7599000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 90615000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 4718000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3448000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 11182000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1266000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1564000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Payables, current",
              "value": 22178000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 26156000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 2091000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 12446000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2020 and 2019",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39373000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 49724000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -6393000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 84492000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,047,935,095 shares in 2020 and 1,038,087,496 shares in 2019",
              "value": 56850000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 27642000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 102000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, ending balance",
              "value": 27744000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 90615000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 22929000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 6471000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 4933000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 4331000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 155000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 318000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 15572000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Profits",
              "value": 7357000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 1128000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 6229000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income (Loss) Attributable to Noncontrolling Interests",
              "value": 8000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 6221000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.46
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.45
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized loss on derivatives, net of reclassifications",
              "value": -16000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": -18000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -99000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -265000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": -200000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 6021000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 6229000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 1869000000
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 20000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 122000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 229000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 202000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 4193000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 4074000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1654000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 77000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1892000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 2545000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Antelliq Corporation, net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 321000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -195000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -2510000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 1967000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1952000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 4445000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1281000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3128000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 40000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -444000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -353000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 2000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 1213000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-20-000009",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2020,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2020-01-01 00:00:00",
        "endDate": "2020-03-31 00:00:00",
        "filedDate": "2020-05-06 00:00:00",
        "acceptedDate": "2020-05-06 16:36:54",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 7425000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 7000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $89 in 2020 and $86 in 2019)",
              "value": 8182000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 5846000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4714000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 26174000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 555000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,706 in 2020 and $17,686 in 2019",
              "value": 15269000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 19767000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 16096000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 7052000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 84913000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 6361000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3572000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 10932000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1033000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1585000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Payables, current",
              "value": 23483000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 21637000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1943000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other liabilities, noncurrent",
              "value": 11550000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2020 and 2019",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39697000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 48272000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -6391000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 83366000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,053,090,194 shares in 2020 and 1,038,087,496 shares in 2019",
              "value": 57161000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 26205000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 95000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, ending balance",
              "value": 26300000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 84913000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 12057000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 3312000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 2555000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 2209000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 72000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -71000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 8219000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Profits",
              "value": 3838000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 619000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3219000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income (loss) attributable to noncontrolling interests",
              "value": 0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net income attributable to Merck & Co., Inc.",
              "value": 3219000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders",
              "value": 1.27
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders",
              "value": 1.26
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 104000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -18000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -60000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -344000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": -198000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 3021000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3219000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 821000000
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 82000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 108000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -143000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 3666000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 707000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 986000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 49000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1816000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 2545000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -136000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -1628000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 3583000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1951000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1281000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1551000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 26000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -316000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -1490000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -63000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -2474000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-19-000042",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2019,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2019-01-01 00:00:00",
        "endDate": "2019-09-30 00:00:00",
        "filedDate": "2019-11-05 00:00:00",
        "acceptedDate": "2019-11-05 16:43:01",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 7869000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 149000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $116 in 2019 and $119 in 2018)",
              "value": 8442000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,515 in 2019 and $1,417 in 2018 classified in Other assets - see Note 6)",
              "value": 5855000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 3827000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 26142000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 2111000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,281 in 2019 and $16,324 in 2018",
              "value": 14287000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 19480000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 12307000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 9004000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 83331000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3411000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3198000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 11768000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 873000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1434000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 20684000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 22677000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1960000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other liabilities, noncurrent",
              "value": 11085000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2019 and 2018",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39561000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45804000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5390000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 81763000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,026,214,892 shares in 2019 and 984,543,979 shares in 2018",
              "value": 54925000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 26838000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 87000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, ending balance",
              "value": 26925000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 83331000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 34972000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 10443000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 7726000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 7324000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 444000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -362000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 26299000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 8673000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 1259000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 7414000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income (Loss) Attributable to Noncontrolling Interests",
              "value": -73000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 7487000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.91
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.89
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": -9000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": 109000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -41000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 14000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 155000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 7642000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 7414000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 2716000000
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 864000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentInProcess",
              "unit": "usd",
              "label": "Charge for acquisition of Peloton Therapeutics, Inc.",
              "value": 982000000
            },
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to collaboration license options",
              "value": 0
            },
            {
              "concept": "us-gaap_GainLossOnContractTermination",
              "unit": "usd",
              "label": "Charge for collaboration termination",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -386000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 306000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -219000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 3469000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 8646000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 2336000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 2380000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 7459000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Antelliq Corporation, net of cash acquired",
              "value": 3620000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Peloton Therapeutics, Inc., net of cash acquired",
              "value": 1040000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 269000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -320000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -1866000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -3892000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 4958000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 3730000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 4290000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 344000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -240000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -6850000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -26000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -96000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-19-000037",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2019,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2019-01-01 00:00:00",
        "endDate": "2019-06-30 00:00:00",
        "filedDate": "2019-08-06 00:00:00",
        "acceptedDate": "2019-08-06 16:34:49",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 6659000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 446000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $122 in 2019 and $119 in 2018)",
              "value": 7964000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,464 in 2019 and $1,417 in 2018 classified in Other assets - see Note 6)",
              "value": 5847000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 3382000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 24298000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 3779000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,049 in 2019 and $16,324 in 2018",
              "value": 13862000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 19490000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 13381000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 9155000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 83965000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3816000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3142000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 11054000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 634000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1439000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 20085000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 22771000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 2089000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 11283000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2019 and 2018",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39484000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45295000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5362000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 81205000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,010,308,500 shares in 2019 and 984,543,979 shares in 2018",
              "value": 53570000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 27635000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 102000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 27737000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 83965000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 22575000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 6453000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 5138000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 4119000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 212000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -327000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 16249000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 6326000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 820000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 5506000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income (loss) attributable to noncontrolling interests",
              "value": -79000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 5585000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.17
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.15
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -100000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": 126000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -26000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 131000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 183000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 5768000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 5506000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 1871000000
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 252000000
            },
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to collaboration license options",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -149000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 204000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -114000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 3378000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 4420000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1377000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 1810000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 4935000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Antelliq Corporation, net of cash acquired",
              "value": 3620000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 270000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -85000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -2057000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -3532000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 4958000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 2325000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2896000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 304000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -207000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -3698000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 28000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Decrease in Cash, Cash Equivalents and Restricted Cash",
              "value": -1307000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-19-000019",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2019,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2019-01-01 00:00:00",
        "endDate": "2019-03-31 00:00:00",
        "filedDate": "2019-05-08 00:00:00",
        "acceptedDate": "2019-05-08 16:34:31",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8076000000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "Short-term investments",
              "value": 722000000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $116 in 2019 and $119 in 2018)",
              "value": 7608000000,
              "concept": "AccountsReceivableNetCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventories",
              "value": 5712000000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "Other current assets",
              "value": 3233000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Current Assets",
              "value": 25351000000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Investments",
              "value": 5621000000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,623 in 2019 and $16,324 in 2018",
              "value": 13506000000,
              "concept": "PropertyPlantAndEquipmentNet"
            },
            {
              "unit": "usd",
              "label": "Goodwill impairment charges",
              "value": 18170000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 10999000000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "Other Assets",
              "value": 8707000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Assets",
              "value": 82354000000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3175000000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3018000000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 10081000000,
              "concept": "OtherLiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 807000000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1462000000,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Current Liabilities",
              "value": 18543000000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 22721000000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1835000000,
              "concept": "DeferredIncomeTaxLiabilitiesNet"
            },
            {
              "unit": "usd",
              "label": "Other liabilities, noncurrent",
              "value": 11585000000,
              "concept": "OtherLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2019 and 2018",
              "value": 1788000000,
              "concept": "CommonStockValue"
            },
            {
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 38768000000,
              "concept": "AdditionalPaidInCapitalCommonStock"
            },
            {
              "unit": "usd",
              "label": "Retained earnings",
              "value": 44065000000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5346000000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 79275000000,
              "concept": "StockholdersEquityBeforeTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "Treasury stock shares purchased",
              "value": 51736000000,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "Equity, beginning balance",
              "value": 27539000000,
              "concept": "StockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "Distributions attributable to noncontrolling interests",
              "value": 131000000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "Equity, beginning balance",
              "value": 27670000000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 82354000000,
              "concept": "LiabilitiesAndStockholdersEquity"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "Net income",
              "value": 2862000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 898000000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 104000000,
              "concept": "GoodwillAndIntangibleAssetImpairment"
            },
            {
              "unit": "usd",
              "label": "Charge for future payments related to collaboration license options",
              "value": 0,
              "concept": "mrk:ChargeForLicenseOptionsRelatedToCollaboration"
            },
            {
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 194000000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "Expected dividend yield",
              "value": 93000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "Other",
              "value": -120000000,
              "concept": "OtherNoncashIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2935000000,
              "concept": "IncreaseDecreaseInOperatingCapital"
            },
            {
              "unit": "usd",
              "label": "Cash Flows from Operating Activities",
              "value": 1336000000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 595000000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 974000000,
              "concept": "PaymentsToAcquireMarketableSecurities"
            },
            {
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1899000000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "Other",
              "value": -38000000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Cash Flows from Investing Activities",
              "value": 368000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -4135000000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebt"
            },
            {
              "unit": "usd",
              "label": "Payments on debt",
              "value": 0,
              "concept": "RepaymentsOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 4958000000,
              "concept": "ProceedsFromIssuanceOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1090000000,
              "concept": "PaymentsForRepurchaseOfCommonStock"
            },
            {
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1428000000,
              "concept": "PaymentsOfDividendsCommonStock"
            },
            {
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 173000000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "Other",
              "value": -92000000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "Cash Flows from Financing Activities",
              "value": -1614000000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 20000000,
              "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 110000000,
              "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"
            }
          ],
          "ic": [
            {
              "unit": "usd",
              "label": "Net income attributable to Merck & Co., Inc.",
              "value": 2915000000,
              "concept": "NetIncomeLoss"
            },
            {
              "unit": "usd",
              "label": "Net unrealized loss on derivatives, net of reclassifications",
              "value": -48000000,
              "concept": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"
            },
            {
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": 82000000,
              "concept": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"
            },
            {
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -15000000,
              "concept": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"
            },
            {
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 150000000,
              "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"
            },
            {
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": 199000000,
              "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"
            },
            {
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 3114000000,
              "concept": "ComprehensiveIncomeNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Sales",
              "value": 10816000000,
              "concept": "Revenues"
            },
            {
              "unit": "usd",
              "label": "Cost of sales",
              "value": 3052000000,
              "concept": "CostOfGoodsAndServicesSold"
            },
            {
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 2425000000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "Research and development",
              "value": 1931000000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 153000000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -188000000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 7749000000,
              "concept": "mrk:CostsExpensesAndOther"
            },
            {
              "unit": "usd",
              "label": "Profits",
              "value": 3067000000,
              "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 205000000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "Net income",
              "value": 2862000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": -53000000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd/shares",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 1.13,
              "concept": "EarningsPerShareBasic"
            },
            {
              "unit": "usd/shares",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 1.12,
              "concept": "EarningsPerShareDiluted"
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-18-000039",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2018,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2018-01-01 00:00:00",
        "endDate": "2018-09-30 00:00:00",
        "filedDate": "2018-11-06 00:00:00",
        "acceptedDate": "2018-11-06 16:14:11",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3091000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 7374000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 759000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5151000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39762000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 85130000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 26836000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 7826000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Debt",
              "value": 3656000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 2065000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 3761000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 7500000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1304000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18258000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 12175000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,294 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)",
              "value": 5416000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 85130000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 18586000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 19936000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 2459000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 7606000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 234000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9776000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 11887000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,568 in 2018 and $16,602 in 2017",
              "value": 12755000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 42189000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 32422000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 78588000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 32656000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 918,364,126 shares in 2018 and 880,491,914 shares in 2017",
              "value": 46166000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 25199000000
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 4426000000
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 10220000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings (Loss) per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings (Loss) per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income before taxes",
              "value": 6097000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on income",
              "value": 1682000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income (Loss) Attributable to Merck & Co., Inc.",
              "value": 4393000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 22000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": -56000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -106000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -240000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 223000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": 33000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 512000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 4415000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 7538000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 494000000
            },
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 31296000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 7459000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to collaboration license options",
              "value": 650000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": 1732000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -391000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 3424000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -140000000
            },
            {
              "concept": "us-gaap_GainLossOnContractTermination",
              "unit": "usd",
              "label": "Charge for collaboration termination",
              "value": -420000000
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2034000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -7594000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Investing Activities",
              "value": 2136000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 7330000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -585000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 150000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 3158000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3895000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions, net of cash acquired",
              "value": 372000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 6899000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1686000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -289000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 2294000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 11243000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 461000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 4415000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 3007000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 261000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-18-000034",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2018,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2018-01-01 00:00:00",
        "endDate": "2018-06-30 00:00:00",
        "filedDate": "2018-08-07 00:00:00",
        "acceptedDate": "2018-08-07 16:32:58",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3024000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $210 in both 2018 and 2017)",
              "value": 7287000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 661000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5122000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39741000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 85040000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 24064000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 5310000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Debt",
              "value": 3379000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 2159000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4005000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 7145000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1309000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18274000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 12898000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,361 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)",
              "value": 5178000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 85040000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 18128000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 19959000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 2284000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 10033000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 237000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9755000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 12028000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,567 in 2018 and $16,602 in 2017",
              "value": 12626000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 41523000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 32529000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 77930000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, ending balance",
              "value": 32766000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 907,061,576 shares in 2018 and 880,491,914 shares in 2017",
              "value": 45401000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 17070000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 2505000000
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 6601000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 3432000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 975000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 2443000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 14000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": -96000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service credit, net of amortization",
              "value": -66000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -104000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 196000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": 62000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 340000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 2457000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 5470000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 323000000
            },
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 20502000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 5016000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to Eisai collaboration license options",
              "value": 650000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -784000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -258000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 2363000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -108000000
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 1274000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -5689000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Investing Activities",
              "value": 476000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 4537000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -429000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 274000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 2162000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2610000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 372000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 5248000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1033000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -277000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 2069000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 7403000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 299000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 2457000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 3008000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 170000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-18-000011",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2018,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2018-01-01 00:00:00",
        "endDate": "2018-03-31 00:00:00",
        "filedDate": "2018-05-08 00:00:00",
        "acceptedDate": "2018-05-08 16:31:56",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3162000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 7245000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 717000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5060000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39874000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 86041000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 24085000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 4483000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Debt",
              "value": 2055000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 2206000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4112000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 6558000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1317000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18304000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 13500000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 5382000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 86041000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 16960000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 21501000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 2863000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 11033000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 233000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9709000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 11473000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,483 in 2018 and $16,602 in 2017",
              "value": 12561000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 41107000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 33668000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 77709000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, ending balance",
              "value": 33901000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 884,622,139 shares in 2018 and 880,491,914 shares in 2017",
              "value": 44041000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 8692000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 860000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 3184000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Profits",
              "value": 1345000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on income",
              "value": 604000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 736000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 5000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -99000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -36000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized loss on derivatives, net of reclassifications",
              "value": -70000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 257000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": 124000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 291000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 741000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 3196000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 95000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 10037000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 2508000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to Eisai collaboration license options",
              "value": 650000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -1610000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -30000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 1137000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 154000000
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 1473000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities",
              "value": -2722000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -197000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 1155000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -50000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 269000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 566000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1299000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions of businesses, net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 1326000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 450000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -83000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -1000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1848000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 230000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 741000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1003000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 80000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-17-000045",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2017,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2017-01-01 00:00:00",
        "endDate": "2017-09-30 00:00:00",
        "filedDate": "2017-11-07 00:00:00",
        "acceptedDate": "2017-11-07 16:38:23",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2620000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $222 in 2017 and $195 in 2016)",
              "value": 7671000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 396000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4945000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39823000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 91676000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 27919000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 7901000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 5157000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 3790000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5884000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 4159000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1302000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18340000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 15138000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,029 in 2017 and $1,117 in 2016 classified in Other assets - see Note 5)",
              "value": 5263000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 91676000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 19467000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 21838000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 3294000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 12206000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 251000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9992000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7713000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,661 in 2017 and $15,749 in 2016",
              "value": 12189000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 43701000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 38248000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 80367000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 38499000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 850,698,697 shares in 2017 and 828,372,200 shares in 2016",
              "value": 42119000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 25047000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 3721000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 9369000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic (loss) earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "(Loss) earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Profits",
              "value": 4642000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 1186000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net (loss) income attributable to Merck & Co., Inc.",
              "value": 3440000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 16000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": 213000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -86000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized loss on derivatives, net of reclassifications",
              "value": -441000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 423000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 281000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -30000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3456000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 7927000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 470000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 29689000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 7251000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to AstraZeneca collaboration license options",
              "value": 750000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash and Cash Equivalents",
              "value": 1386000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -601000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 3509000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 438000000
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 376000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 5259000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -4221000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Investing Activities",
              "value": 2737000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 2432000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 31000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -121000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 2312000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3884000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions of businesses, net of cash acquired",
              "value": 347000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 8397000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1173000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -167000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 1962000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 12533000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 481000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3456000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 301000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 232000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-17-000037",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2017,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2017-01-01 00:00:00",
        "endDate": "2017-06-30 00:00:00",
        "filedDate": "2017-08-08 00:00:00",
        "acceptedDate": "2017-08-08 16:39:40",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2934000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $200 in 2017 and $195 in 2016)",
              "value": 7439000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1979000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5094000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39776000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 92804000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 28167000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 7786000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3181000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 3354000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5928000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 4560000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1301000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18358000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 16119000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 5407000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 92804000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 18758000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 21706000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 4181000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 12138000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 249000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9363000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8068000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,375 in 2017 and $15,749 in 2016",
              "value": 12094000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45046000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 39463000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 81516000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 39712000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 849,974,743 shares in 2017 and 828,372,200 shares in 2016",
              "value": 42053000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 14923000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 3628000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 6095000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Profits",
              "value": 4442000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 935000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 3496000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 11000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain on investments, net of reclassifications",
              "value": 78000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -73000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized loss on derivatives, net of reclassifications",
              "value": -375000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 356000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 132000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -117000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 3507000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 3545000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 317000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 19365000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 4849000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash and Cash Equivalents",
              "value": 1271000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -272000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 2355000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 359000000
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 131000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2337000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -4757000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Investing Activities",
              "value": 2066000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 3603000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -63000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -62000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 2153000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2601000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions of businesses, net of cash acquired",
              "value": 347000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 6280000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 732000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -86000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -24000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 9363000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 408000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 3507000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 301000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 156000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-17-000016",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2017,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2017-01-01 00:00:00",
        "endDate": "2017-03-31 00:00:00",
        "filedDate": "2017-05-09 00:00:00",
        "acceptedDate": "2017-05-09 16:39:34",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2484000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $195 in 2017 and 2016)",
              "value": 7066000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 2330000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5080000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39899000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 96561000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 31530000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 11700000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 5037000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4069000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5872000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 4889000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1314000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18358000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 16863000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,090 in 2017 and $1,117 in 2016 classified in Other assets - see Note 5)",
              "value": 5146000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 96561000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 19823000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 23437000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 3541000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 11896000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 251000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 8658000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8324000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,171 in 2017 and $15,749 in 2016",
              "value": 12042000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 44387000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 39837000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 80994000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 40088000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 836,667,641 shares in 2017 and 828,372,200 shares in 2016",
              "value": 41157000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 7431000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 1697000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 3015000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Profits",
              "value": 2003000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 447000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net income attributable to Merck & Co., Inc.",
              "value": 1551000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 5000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain on investments, net of reclassifications",
              "value": 43000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -26000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized loss on derivatives, net of reclassifications",
              "value": -232000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 309000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 146000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -58000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 1556000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 1796000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 151000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 9434000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 2411000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase in Cash and Cash Equivalents",
              "value": 5193000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -54000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 1193000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 253000000
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 80000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2535000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Financing Activities",
              "value": 1461000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Investing Activities",
              "value": 3193000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 286000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 28000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 52000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1019000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1294000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions of businesses, net of cash acquired",
              "value": 306000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 2929000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 339000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -23000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 3784000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 6819000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 313000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 1556000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 300000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 74000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-16-000098",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2016,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2016-01-01 00:00:00",
        "endDate": "2016-09-30 00:00:00",
        "filedDate": "2016-11-07 00:00:00",
        "acceptedDate": "2016-11-07 16:19:24",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2481000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $173 in 2016 and $165 in 2015) (excludes accounts receivable of $10 in 2016 and 2015 classified in Other assets)",
              "value": 7364000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1208000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -4252000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39897000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 98335000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 29440000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 7900000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2016 and 2015",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 1487000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 3765000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 6443000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 6374000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1292000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18260000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 20506000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 5244000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 98335000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 15555000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 23656000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 5160000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 11657000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 213000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9087000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8793000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,022 in 2016 and $15,923 in 2015",
              "value": 12029000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 46028000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 43744000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 83461000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, Ending Balance",
              "value": 43957000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 815,442,334 shares in 2016 and 795,975,449 shares in 2015",
              "value": 39717000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 23677000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 4411000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 10559000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 6015000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Tax expense (benefit)",
              "value": 1487000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 4515000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 13000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": 96000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 280000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized loss on derivatives, net of reclassifications",
              "value": -367000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 447000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -104000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -88000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 4528000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 5475000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 386000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 29692000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 7169000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash and Cash Equivalents",
              "value": -617000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -65000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 4286000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 353000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 12000000
            },
            {
              "concept": "us-gaap_ForeignCurrencyTransactionGainLossRealized",
              "unit": "usd",
              "label": "Foreign currency devaluation related to Venezuela",
              "value": 0
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 572000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 59000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 3002000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -7067000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -647000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 6744000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -247000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 22000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 2418000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3853000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Cubist Pharmaceuticals, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions of other businesses, net of cash acquired",
              "value": 778000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 10084000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1063000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 8000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -117000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 909000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 11300000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 790000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 4528000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2386000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 225000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-16-000094",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2016,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2016-01-01 00:00:00",
        "endDate": "2016-06-30 00:00:00",
        "filedDate": "2016-08-08 00:00:00",
        "acceptedDate": "2016-08-08 16:37:27",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2514000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $167 in 2016 and $165 in 2015) (excludes accounts receivable of $10 in 2016 and 2015 classified in Other assets)",
              "value": 6916000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1213000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4086000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39911000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 96475000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 27926000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 6600000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2016 and 2015",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 644000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 3928000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 6559000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 6091000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1292000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 17809000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 20315000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 5248000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 96475000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 14918000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 23642000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 5226000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 11879000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 89000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9255000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8378000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,005 in 2016 and $15,923 in 2015",
              "value": 11987000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45121000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 43357000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 82734000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 43446000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 811,476,036 shares in 2016 and 795,975,449 shares in 2015",
              "value": 39377000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 16028000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 2392000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 7150000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 3128000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 789000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 2330000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 9000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": 126000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 136000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -293000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 365000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 62000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -67000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 2339000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 3810000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 225000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 19156000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 4776000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Decrease in Cash and Cash Equivalents",
              "value": -1916000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -120000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 3111000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 300000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 7000000
            },
            {
              "concept": "us-gaap_ForeignCurrencyTransactionGainLossRealized",
              "unit": "usd",
              "label": "Foreign currency devaluation related to Venezuela",
              "value": 0
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 567000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 38000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 2438000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -6232000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Investing Activities",
              "value": 243000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 3773000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -197000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -21000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1573000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2579000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Cubist Pharmaceuticals, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions of other businesses, net of cash acquired",
              "value": 157000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 6355000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 654000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 8000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -109000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -9000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 7388000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 381000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 2339000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2351000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 148000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-16-000066",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2016,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2016-01-01 00:00:00",
        "endDate": "2016-03-31 00:00:00",
        "filedDate": "2016-05-09 00:00:00",
        "acceptedDate": "2016-05-09 16:32:41",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2241000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $186 in 2016 and $165 in 2015) (excludes accounts receivable of $10 in 2016 and 2015 classified in Other assets)",
              "value": 6850000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1864000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -4194000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40145000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 98755000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 28772000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 9716000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2016 and 2015",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2113000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 3877000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5921000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 6256000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1307000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 17784000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 21364000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,258 in 2016 and $1,569 in 2015 classified in Other assets)",
              "value": 5102000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 98755000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 17568000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 23656000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 3227000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 12554000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 95000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 10043000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7374000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,052 in 2016 and $15,923 in 2015",
              "value": 12360000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45192000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 43806000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 82931000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 43901000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 807,550,812 shares in 2016 and 795,975,449 shares in 2015",
              "value": 39125000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 7688000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 1079000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 3572000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 1624000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 494000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 1125000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 5000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized gain on investments, net of reclassifications",
              "value": 63000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (credit) cost, net of amortization",
              "value": 28000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -202000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 121000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -46000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -48000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1130000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 1659000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 91000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 9312000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 2318000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase in Cash and Cash Equivalents",
              "value": 1192000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -70000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 1561000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 144000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 4000000
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 277000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 34000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 875000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities",
              "value": -2851000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Investing Activities",
              "value": 1741000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 2158000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -97000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 86000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 913000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1279000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Cubist Pharmaceuticals, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions of other businesses, net of cash acquired",
              "value": 147000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 2367000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 279000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -10000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 4620000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 202000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1130000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 851000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 68000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-15-000058",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2015,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2015-01-01 00:00:00",
        "endDate": "2015-09-30 00:00:00",
        "filedDate": "2015-11-05 00:00:00",
        "acceptedDate": "2015-11-05 16:32:00",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2023000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $163 in 2015 and $153 in 2014) (excludes accounts receivable of $30 in 2015 and $80 in 2014 classified in Other assets)",
              "value": 6414000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 2119000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -4573000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40139000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 101232000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 28567000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 7548000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2015 and 2014",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2543000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 4941000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5618000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 5959000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1288000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 17761000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 23724000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 5123000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 101232000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 17583000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 24124000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 4541000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 13080000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 92000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9610000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7887000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,043 in 2015 and $18,004 in 2014",
              "value": 12482000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45660000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 45587000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 83014000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, Ending Balance",
              "value": 45679000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 774,869,058 shares in 2015 and 738,963,326 shares in 2014",
              "value": 37427000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 24698000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 3215000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 11084000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 4585000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income tax expense (benefit)",
              "value": 1108000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 3465000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 12000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -35000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -106000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -42000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -279000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -250000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -624000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3477000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 4906000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 386000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 29283000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 7698000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash and Cash Equivalents",
              "value": 107000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -846000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 4815000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -1063000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 12000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on AstraZeneca option exercise",
              "value": 0
            },
            {
              "concept": "us-gaap_ForeignCurrencyTransactionGainLossRealized",
              "unit": "usd",
              "label": "Foreign exchange losses related to Venezuela",
              "value": -715000000
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 80000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 210000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 787000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -2863000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -4141000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 8174000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -697000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -100000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 3005000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3854000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Cubist Pharmaceuticals, Inc., net of cash acquired",
              "value": 7598000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Idenix Pharmaceuticals, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 110000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 12425000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 790000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 151000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 7938000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 55000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -1526000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 16531000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments",
              "unit": "usd",
              "label": "Proceeds from AstraZeneca option exercise",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 434000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3477000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2905000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 221000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-15-000053",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2015,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2015-01-01 00:00:00",
        "endDate": "2015-06-30 00:00:00",
        "filedDate": "2015-08-06 00:00:00",
        "acceptedDate": "2015-08-06 16:17:10",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2335000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $149 in 2015 and $153 in 2014) (excludes accounts receivable of $50 in 2015 and $80 in 2014 classified in Other assets - see Note 4)",
              "value": 6510000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1878000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4332000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40114000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 102582000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 28319000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 6922000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2015 and 2014",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2483000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 5133000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5843000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 6454000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1295000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 17707000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 24750000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,724 in 2015 and $1,664 in 2014 classified in Other assets - see Note 5)",
              "value": 5306000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 102582000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 17508000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 24069000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 4448000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 13333000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 190000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9517000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7913000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,306 in 2015 and $18,004 in 2014",
              "value": 12630000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45103000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 46448000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 82673000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, Ending Balance",
              "value": 46638000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 753,147,765 shares in 2015 and 738,963,326 shares in 2014",
              "value": 36225000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 17022000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 1630000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 7323000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 2188000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income Tax Provision (Benefit)",
              "value": 542000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 1639000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 7000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": 32000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": 76000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -194000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive loss",
              "value": -9000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -77000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -793000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1646000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 3407000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 273000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 19210000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 5226000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 73000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Decrease in Cash and Cash Equivalents",
              "value": -519000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income tax benefit",
              "value": -383000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 3245000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -978000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 7000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on AstraZeneca option exercise",
              "value": 0
            },
            {
              "concept": "us-gaap_ForeignCurrencyTransactionGainLossRealized",
              "unit": "usd",
              "label": "Foreign exchange losses related to Venezuela",
              "value": -715000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 147000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 1010000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -330000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -4080000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 4869000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -577000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 40000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1724000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2582000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Cubist Pharmaceuticals, Inc., net of cash acquired",
              "value": 7598000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 8621000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 474000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 25000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 7940000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 93000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -1529000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 12628000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments",
              "unit": "usd",
              "label": "Proceeds from AstraZeneca option exercise",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 377000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1646000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Repayments of Long-term Debt",
              "value": 2905000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 146000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-15-000008",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2015,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2015-01-01 00:00:00",
        "endDate": "2015-03-31 00:00:00",
        "filedDate": "2015-05-07 00:00:00",
        "acceptedDate": "2015-05-07 16:34:55",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2091000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $141 in 2015 and $153 in 2014) (excludes accounts receivable of $65 in 2015 and $80 in 2014 classified in Other assets - see Note 4)",
              "value": 6670000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 2450000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4167000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40355000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 108345000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 32927000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 7980000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2015 and 2014",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 4728000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 5117000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5596000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 6803000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1306000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 17740000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 26080000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,578 in 2015 and $1,664 in 2014 classified in Other assets - see Note 5)",
              "value": 5539000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 108345000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 20442000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 25506000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 7621000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 13092000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 152000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9867000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7677000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,794 in 2015 and $18,004 in 2014",
              "value": 12910000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45692000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 47765000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 83668000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 47917000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 748,715,051 shares in 2015 and 738,963,326 shares in 2014",
              "value": 35903000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 8044000000
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 1109000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 3569000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 1381000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income tax expense (benefit)",
              "value": 423000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 953000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 5000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": 46000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 252000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -177000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 156000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -35000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -55000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 958000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 1737000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 82000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 9425000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 2601000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 14000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase in Cash and Cash Equivalents",
              "value": 539000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income tax expense (benefit)",
              "value": -179000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 1637000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -295000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 3000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 145000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 618000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Financing Activities",
              "value": 5155000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -6605000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 2284000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -551000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 52000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1015000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1280000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 7598000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 5039000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 203000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 7941000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -8000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 2177000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 6287000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 242000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 958000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2902000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 63000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-14-000071",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2014,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2014-01-01 00:00:00",
        "endDate": "2014-09-30 00:00:00",
        "filedDate": "2014-11-10 00:00:00",
        "acceptedDate": "2014-11-10 07:50:49",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2279000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $186 in 2014 and $146 in 2013) (excludes accounts receivable of $275 in 2014 and 2013 classified in Other assets - see Note 4)",
              "value": 6515000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 2467000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -2998000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40340000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 101808000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 34723000000
            },
            {
              "concept": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Assets of Disposal Group, Including Discontinued Operation, Current",
              "value": 3302000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 11370000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2014 and 2013",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 9275000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 4740000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 6589000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 4987000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1288000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 13171000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 20395000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,774 in 2014 and $1,704 in 2013 classified in Other assets - see Note 5)",
              "value": 5819000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 101808000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 25927000000
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Liabilities of Disposal Group, Including Discontinued Operation, Current",
              "value": 810000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 18566000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 2977000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 13492000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 136000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9808000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 6968000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,761 in 2014 and $18,121 in 2013",
              "value": 13438000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 39989000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 45224000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 79119000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, Ending Balance",
              "value": 45360000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 716,260,636 shares in 2014 and 649,576,808 shares in 2013",
              "value": 33895000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 3803000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 13019000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 5472000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 241000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income tax benefit",
              "value": 865000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 4604000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 3000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": 33000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 149000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -188000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": -801000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 795000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 737000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 4607000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 4897000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 664000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 31755000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 8681000000
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 26283000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 1209000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash and Cash Equivalents",
              "value": -4251000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -1773000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 5118000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -227000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 132000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on AstraZeneca option exercise",
              "value": 741000000
            },
            {
              "concept": "us-gaap_GainLossOnSaleOfBusiness",
              "unit": "usd",
              "label": "Gain on divestiture of certain ophthalmic products",
              "value": 396000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 241000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": -950000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -5470000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -7578000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 9024000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 50000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 94000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 6083000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3911000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Idenix Pharmaceuticals, Inc., net of cash acquired",
              "value": 3700000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 16231000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 827000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 1048000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 1000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 72000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 3077000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 11807000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments",
              "unit": "usd",
              "label": "Proceeds from AstraZeneca option exercise",
              "value": 419000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 1381000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 4607000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 7000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 209000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-14-000063",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2014,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2014-01-01 00:00:00",
        "endDate": "2014-06-30 00:00:00",
        "filedDate": "2014-08-07 00:00:00",
        "acceptedDate": "2014-08-07 17:04:54",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2326000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $167 in 2014 and $146 in 2013) (excludes accounts receivable of $275 in 2014 and 2013 classified in Other assets - see Note 4)",
              "value": 7022000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 192000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -2444000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40199000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 97860000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 33587000000
            },
            {
              "concept": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Assets of Disposal Group, Including Discontinued Operation, Current",
              "value": 3375000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 9743000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2014 and 2013",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 4477000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 3659000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 7143000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 4651000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1303000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 11789000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 18830000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 6136000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 97860000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 17928000000
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Liabilities of Disposal Group, Including Discontinued Operation, Current",
              "value": 801000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 18590000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 3652000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 12618000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 158000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 8829000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8175000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,866 in 2014 and $18,121 in 2013",
              "value": 13893000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 40366000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 48358000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 79909000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, Ending Balance",
              "value": 48516000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 677,393,158 shares in 2014 and 649,576,808 shares in 2013",
              "value": 31551000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 3462000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 8796000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 3982000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 217000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 218000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 3709000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 55000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": 62000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -105000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 128000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": -247000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (credit) cost, net of amortization",
              "value": 332000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 596000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3764000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 3238000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 288000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 21198000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 5707000000
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 17216000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 660000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash and Cash Equivalents",
              "value": -5878000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income tax expense (benefit) related to AstraZeneca option exercise",
              "value": -1246000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 3507000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 51000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 125000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on AstraZeneca option exercise",
              "value": 741000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 217000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 1118000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -6749000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -3856000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 4676000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 192000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 48000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 3413000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2629000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 12380000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 507000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 558000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 1000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 49000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -1886000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 8102000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments",
              "unit": "usd",
              "label": "Proceeds from AstraZeneca option exercise",
              "value": 419000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 1134000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3764000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 5000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 134000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-14-000033",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2014,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2014-01-01 00:00:00",
        "endDate": "2014-03-31 00:00:00",
        "filedDate": "2014-05-08 00:00:00",
        "acceptedDate": "2014-05-08 16:55:35",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2434000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $171 in 2014 and $146 in 2013) (excludes accounts receivable of $275 in 2014 and 2013 classified in Other assets - see Note 4)",
              "value": 7188000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 595000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -2179000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40450000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 108460000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 41240000000
            },
            {
              "concept": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Assets held for sale",
              "value": 3224000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 15828000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2014 and 2013",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 8559000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 3939000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 8831000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 5881000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1327000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12120000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 20517000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 6376000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 108460000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 22470000000
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Liabilities held for sale",
              "value": 848000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 19589000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 4685000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 11456000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 2589000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 8707000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7956000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,622 in 2014 and $18,121 in 2013",
              "value": 14296000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 39661000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 49975000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 79720000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, Ending Balance",
              "value": 52564000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 647,565,088 shares in 2014 and 649,576,808 shares in 2013",
              "value": 29745000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 1723000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 3903000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 2091000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 124000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 360000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 1705000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 26000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -2000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -66000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 87000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": 18000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (credit) cost, net of amortization",
              "value": 1000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 39000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1731000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 1574000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 125000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 10264000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 2734000000
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 8173000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash and Cash Equivalents",
              "value": 207000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -304000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 1754000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 33000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 66000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 124000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 703000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Financing Activities",
              "value": 1620000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -3807000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 2361000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 115000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -58000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1167000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1290000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 6825000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 205000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 533000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 3149000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 2632000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 931000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1731000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 3000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 56000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-13-000011",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2013,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2013-01-01 00:00:00",
        "endDate": "2013-09-30 00:00:00",
        "filedDate": "2013-11-07 00:00:00",
        "acceptedDate": "2013-11-07 16:59:25",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2469000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $140 in 2013 and $163 in 2012) (excludes accounts receivable of $490 in 2013 and $473 in 2012 classified in Other assets - see Note 4)",
              "value": 7578000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1298000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -4698000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39909000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 106419000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 37765000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 14090000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2013 and 2012",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3976000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 5277000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 7010000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes and Noncurrent Liabilities",
              "value": 15551000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1289000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12121000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 25002000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 6741000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 106419000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 18215000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 22647000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 4079000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 9198000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 2587000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9183000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,805 in 2013 and $17,385 in 2012",
              "value": 15323000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 39773000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 47419000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 76772000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Equity, Ending Balance",
              "value": 50006000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 650,490,309 shares in 2013 and 550,468,221 shares in 2012",
              "value": 29353000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 3607000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 12347000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 4320000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 351000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 618000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 3623000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 79000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": -37000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": 169000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -409000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Total Other Comprehensive (Loss) Income, Net of Taxes",
              "value": -16000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service cost, net of amortization",
              "value": -261000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -656000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3702000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 5668000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 1144000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 32713000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 8929000000
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 28393000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 594000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase in Cash and Cash Equivalents",
              "value": 639000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -532000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 5034000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -298000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 178000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 351000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 494000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -3366000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -4325000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 8628000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -287000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -48000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 6320000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3897000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 13077000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1119000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 6467000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -61000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 151000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 9823000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 809000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 3702000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 515000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 210000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-13-000004",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2013,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2013-01-01 00:00:00",
        "endDate": "2013-06-30 00:00:00",
        "filedDate": "2013-08-07 00:00:00",
        "acceptedDate": "2013-08-07 17:01:07",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2253000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $137 in 2013 and $163 in 2012) (excludes accounts receivable of $490 in 2013 and $473 in 2012 classified in Other assets - see Note 4)",
              "value": 7779000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 409000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4760000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39891000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 106876000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 36995000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 15090000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2013 and 2012",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 5582000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 4352000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 7112000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes and Noncurrent Liabilities",
              "value": 15843000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1286000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12198000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 26333000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,515 in 2013 and $1,606 in 2012 classified in Other assets - see Note 5)",
              "value": 6766000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 106876000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 18402000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 22526000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 3008000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 8555000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 2605000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 8872000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,594 in 2013 and $17,385 in 2012",
              "value": 15683000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 39915000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders' equity",
              "value": 47500000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 76834000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 50105000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 650,630,672 shares in 2013 and 550,468,221 shares in 2012",
              "value": 29334000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usd/share",
              "label": "Dividends Declared per Common Share, in dollars per share",
              "value": 0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 2421000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 8243000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 2795000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 249000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 244000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 2499000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 52000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -80000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain on derivatives, net of reclassifications",
              "value": 271000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -481000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Total Other Comprehensive (Loss) Income, Net of Taxes",
              "value": -78000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net gain and prior service cost, net of amortization",
              "value": -212000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -484000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 2551000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 4008000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 274000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 21681000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 6126000000
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 18886000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 594000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase in Cash and Cash Equivalents",
              "value": 1639000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -319000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 3329000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -301000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 68000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 249000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": 1809000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -451000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -2288000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 4679000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -372000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -99000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 6105000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2638000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 8818000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 764000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 6467000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -3000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 1702000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 7195000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 641000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 2551000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 515000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation expense",
              "value": 142000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001193125-13-211374",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2013,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2013-01-01 00:00:00",
        "endDate": "2013-03-31 00:00:00",
        "filedDate": "2013-05-09 00:00:00",
        "acceptedDate": "2013-05-09 17:05:03",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "_usd",
              "label": "Deferred Income Taxes And Other Assets Noncurrent",
              "value": 6891000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
              "unit": "_usd",
              "label": "Deferred Income Taxes And Other Liabilities Noncurrent",
              "value": 15703000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "_usd",
              "label": "Stockholders Equity Before Treasury Stock",
              "value": 78158000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "_usd",
              "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest",
              "value": 55606000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "_usd",
              "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
              "value": -4629000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "_usd",
              "label": "Liabilities Current",
              "value": 18802000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "_usd",
              "label": "Retained Earnings Accumulated Deficit",
              "value": 40272000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "_usd",
              "label": "Assets",
              "value": 106200000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "_usd",
              "label": "Cash And Cash Equivalents At Carrying Value",
              "value": 13024000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "_usd",
              "label": "Accounts Receivable Net Current",
              "value": 7965000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "_usd",
              "label": "Inventory Net",
              "value": 6773000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "_usd",
              "label": "Minority Interest",
              "value": 2577000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "_usd",
              "label": "Deferred Income Taxes And Other Assets Current",
              "value": 4484000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "_usd",
              "label": "Marketable Securities Noncurrent",
              "value": 7948000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "_usd",
              "label": "Accrued Income Taxes Current",
              "value": 1075000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "_usd",
              "label": "Debt Current",
              "value": 4736000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "_usd",
              "label": "Liabilities And Stockholders Equity",
              "value": 106200000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "_usd",
              "label": "Common Stock Value",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "_usd",
              "label": "Goodwill",
              "value": 12207000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "_usd",
              "label": "Other Liabilities Current",
              "value": 9569000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "_usd",
              "label": "Intangible Assets Net Excluding Goodwill",
              "value": 28108000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "_usd",
              "label": "Treasury Stock Value",
              "value": 25129000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "_usd",
              "label": "Property Plant And Equipment Net",
              "value": 15802000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "_usd",
              "label": "Marketable Securities Current",
              "value": 2998000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "_usd",
              "label": "Assets Current",
              "value": 35244000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "_usd",
              "label": "Dividends Payable Current",
              "value": 1338000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "_usd",
              "label": "Long Term Debt Noncurrent",
              "value": 16089000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "_usd",
              "label": "Additional Paid In Capital Common Stock",
              "value": 40727000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "_usd",
              "label": "Stockholders Equity",
              "value": 53029000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "_usd",
              "label": "Accounts Payable Current",
              "value": 2084000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "_usd",
              "label": "Other Nonoperating Income Expense",
              "value": -282000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "_usd",
              "label": "Profit Loss",
              "value": 1616000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "_usd",
              "label": "Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax",
              "value": -161000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "_usd",
              "label": "Research And Development Expense",
              "value": 1907000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "_usd",
              "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax",
              "value": -345000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "_usd",
              "label": "Other Comprehensive Income Loss Net Of Tax",
              "value": 53000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "_usd_/_shares",
              "label": "Earnings Per Share Basic",
              "value": 0
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "_usd",
              "label": "Cost Of Goods Sold",
              "value": 3959000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "_usd",
              "label": "Net Income Loss",
              "value": 1593000000
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "_usd_/_shares",
              "label": "Earnings Per Share Diluted",
              "value": 0
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "_usd_/_shares",
              "label": "Common Stock Dividends Per Share Declared",
              "value": 0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "_usd",
              "label": "Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax",
              "value": 236000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "_usd",
              "label": "Selling General And Administrative Expense",
              "value": 2987000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "_usd",
              "label": "Income Tax Expense Benefit",
              "value": -66000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "_usd",
              "label": "Net Income Loss Attributable To Noncontrolling Interest",
              "value": 23000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "_usd",
              "label": "Income Loss From Equity Method Investments",
              "value": 133000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "_usd",
              "label": "Sales Revenue Goods Net",
              "value": 10671000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "_usd",
              "label": "Restructuring Charges",
              "value": 119000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "_usd",
              "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
              "value": 1550000000
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "_usd",
              "label": "Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest",
              "value": 1646000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "_usd",
              "label": "Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax",
              "value": 1000000
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "_usd",
              "label": "Costs, expenses and other.",
              "value": 9121000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "_usd",
              "label": "Asset Impairment Charges",
              "value": 30000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "_usd",
              "label": "Depreciation Depletion And Amortization",
              "value": 1674000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "_usd",
              "label": "Proceeds From Stock Options Exercised",
              "value": 92000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "_usd",
              "label": "Repayments Of Long Term Debt",
              "value": 506000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "_usd",
              "label": "Profit Loss",
              "value": 1616000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "_usd",
              "label": "Net Cash Provided By Used In Investing Activities",
              "value": -1153000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "_usd",
              "label": "Increase Decrease In Operating Capital",
              "value": 1173000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "_usd",
              "label": "Equity Method Investment Dividends Or Distributions",
              "value": 5000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "_usd",
              "label": "Share Based Compensation",
              "value": 67000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "_usd",
              "label": "Proceeds From Repayments Of Short Term Debt",
              "value": 880000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "_usd",
              "label": "Cash And Cash Equivalents Period Increase Decrease",
              "value": -427000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "_usd",
              "label": "Other Noncash Income Expense",
              "value": -326000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "_usd",
              "label": "Proceeds From Sale Maturity And Collections Of Investments",
              "value": 3161000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "_usd",
              "label": "Deferred Income Tax Expense Benefit",
              "value": -71000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "_usd",
              "label": "Proceeds From Payments For Other Financing Activities",
              "value": -1000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "_usd",
              "label": "Payments For Repurchase Of Common Stock",
              "value": 580000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "_usd",
              "label": "Net Cash Provided By Used In Financing Activities",
              "value": -1421000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "_usd",
              "label": "Effect Of Exchange Rate On Cash And Cash Equivalents",
              "value": -194000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "_usd",
              "label": "Payments To Acquire Productive Assets",
              "value": 351000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "_usd",
              "label": "Income Loss From Equity Method Investments",
              "value": 133000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "_usd",
              "label": "Payments Of Dividends Common Stock",
              "value": 1306000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "_usd",
              "label": "Payments To Acquire Marketable Securities",
              "value": 4010000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "_usd",
              "label": "Payments For Proceeds From Other Investing Activities",
              "value": -47000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "_usd",
              "label": "Net Cash Provided By Used In Operating Activities",
              "value": 2341000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001193125-12-463586",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2012,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2012-01-01 00:00:00",
        "endDate": "2012-09-30 00:00:00",
        "filedDate": "2012-11-09 00:00:00",
        "acceptedDate": "2012-11-09 17:02:13",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "Marketable Securities Noncurrent",
              "value": 5560000000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Property Plant And Equipment Net",
              "value": 15884000000,
              "concept": "PropertyPlantAndEquipmentNet"
            },
            {
              "unit": "usd",
              "label": "Goodwill",
              "value": 12168000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "Intangible Assets Net Excluding Goodwill",
              "value": 30325000000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes And Other Assets Noncurrent",
              "value": 6135000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Assets",
              "value": 106301000000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Cash And Cash Equivalents At Carrying Value",
              "value": 17360000000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "Marketable Securities Current",
              "value": 757000000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Accounts Receivable Net Current",
              "value": 7952000000,
              "concept": "AccountsReceivableNetCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventory Net",
              "value": 6731000000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes And Other Assets Current",
              "value": 3429000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Assets Current",
              "value": 36229000000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Long Term Debt Noncurrent",
              "value": 17571000000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes And Other Liabilities Noncurrent",
              "value": 14935000000,
              "concept": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Minority Interest",
              "value": 2465000000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest",
              "value": 58212000000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Liabilities And Stockholders Equity",
              "value": 106301000000,
              "concept": "LiabilitiesAndStockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "Debt Current",
              "value": 2029000000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "Accounts Payable Current",
              "value": 1804000000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Other Liabilities Current",
              "value": 8923000000,
              "concept": "OtherLiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Accrued Income Taxes Current",
              "value": 1512000000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "Dividends Payable Current",
              "value": 1315000000,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Liabilities Current",
              "value": 15583000000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Common Stock Value",
              "value": 1788000000,
              "concept": "CommonStockValue"
            },
            {
              "unit": "usd",
              "label": "Additional Paid In Capital Common Stock",
              "value": 40471000000,
              "concept": "AdditionalPaidInCapitalCommonStock"
            },
            {
              "unit": "usd",
              "label": "Retained Earnings Accumulated Deficit",
              "value": 40390000000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
              "value": -3040000000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Stockholders Equity Before Treasury Stock",
              "value": 79609000000,
              "concept": "StockholdersEquityBeforeTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "Treasury Stock Value",
              "value": 23862000000,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "Stockholders Equity",
              "value": 55747000000,
              "concept": "StockholdersEquity"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "Depreciation Depletion And Amortization",
              "value": 5317000000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "Asset Impairment Charges",
              "value": 176000000,
              "concept": "AssetImpairmentCharges"
            },
            {
              "unit": "usd",
              "label": "Income Loss From Equity Method Investments",
              "value": 410000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Equity Method Investment Dividends Or Distributions",
              "value": 181000000,
              "concept": "EquityMethodInvestmentDividendsOrDistributions"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Tax Expense Benefit",
              "value": -283000000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "Share Based Compensation",
              "value": 257000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "Other Noncash Income Expense",
              "value": 34000000,
              "concept": "OtherNoncashIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Operating Capital",
              "value": 2341000000,
              "concept": "IncreaseDecreaseInOperatingCapital"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Repayments Of Short Term Debt",
              "value": -280000000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebt"
            },
            {
              "unit": "usd",
              "label": "Payments To Acquire Productive Assets",
              "value": 1176000000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Payments To Acquire Marketable Securities",
              "value": 6891000000,
              "concept": "PaymentsToAcquireMarketableSecurities"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Sale Maturity And Collections Of Investments",
              "value": 5607000000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "Payments For Proceeds From Other Investing Activities",
              "value": -53000000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Net Cash Provided By Used In Investing Activities",
              "value": -2407000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Profit Loss",
              "value": 5350000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Net Cash Provided By Used In Operating Activities",
              "value": 8213000000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "Repayments Of Long Term Debt",
              "value": 4000000,
              "concept": "RepaymentsOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Payments For Repurchase Of Common Stock",
              "value": 1439000000,
              "concept": "PaymentsForRepurchaseOfCommonStock"
            },
            {
              "unit": "usd",
              "label": "Payments Of Dividends Common Stock",
              "value": 3836000000,
              "concept": "PaymentsOfDividendsCommonStock"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Stock Options Exercised",
              "value": 1060000000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Payments For Other Financing Activities",
              "value": -54000000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "Net Cash Provided By Used In Financing Activities",
              "value": -2049000000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "Effect Of Exchange Rate On Cash And Cash Equivalents",
              "value": 72000000,
              "concept": "EffectOfExchangeRateOnCashAndCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "Cash And Cash Equivalents Period Increase Decrease",
              "value": 3829000000,
              "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease"
            }
          ],
          "ic": [
            {
              "unit": "usd",
              "label": "Cost Of Goods Sold",
              "value": 12286000000,
              "concept": "CostOfGoodsSold"
            },
            {
              "unit": "usd",
              "label": "Selling General And Administrative Expense",
              "value": 9386000000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "Research And Development Expense",
              "value": 5944000000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "Restructuring Charges",
              "value": 473000000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "Income Loss From Equity Method Investments",
              "value": 410000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Other Nonoperating Income Expense",
              "value": -446000000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Costs, expenses and other.",
              "value": 28125000000,
              "concept": "mrk:CostsExpensesAndOther"
            },
            {
              "unit": "usd",
              "label": "Sales Revenue Goods Net",
              "value": 35530000000,
              "concept": "SalesRevenueGoodsNet"
            },
            {
              "unit": "usd",
              "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
              "value": 7405000000,
              "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Income Tax Expense Benefit",
              "value": 2055000000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "Profit Loss",
              "value": 5350000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Net Income Loss Attributable To Noncontrolling Interest",
              "value": 89000000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Net Income Loss",
              "value": 5261000000,
              "concept": "NetIncomeLoss"
            },
            {
              "unit": "usd/shares",
              "label": "Earnings Per Share Basic",
              "value": 1.73,
              "concept": "EarningsPerShareBasic"
            },
            {
              "unit": "usd/shares",
              "label": "Earnings Per Share Diluted",
              "value": 1.71,
              "concept": "EarningsPerShareDiluted"
            },
            {
              "unit": "usd/shares",
              "label": "Common Stock Dividends Per Share Declared",
              "value": 1.26,
              "concept": "CommonStockDividendsPerShareDeclared"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax",
              "value": -99000000,
              "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax",
              "value": 62000000,
              "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax",
              "value": -45000000,
              "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax",
              "value": 84000000,
              "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Net Of Tax",
              "value": 92000000,
              "concept": "OtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest",
              "value": 5353000000,
              "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"
            }
          ]
        }
      },
      {
        "accessNumber": "0001193125-12-341189",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2012,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2012-01-01 00:00:00",
        "endDate": "2012-06-30 00:00:00",
        "filedDate": "2012-08-07 00:00:00",
        "acceptedDate": "2012-08-07 17:05:43",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "",
              "value": 16752000000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 698000000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,490 in 2012 and $1,379 in 2011 classified in Other assets - see Note 6)",
              "value": 6249000000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 12158000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 31620000000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 105525000000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Debt, Current",
              "value": 3922000000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1674000000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1091000000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1308000000,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 15057000000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 23968000000,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2479000000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 57673000000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16912000000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 35639000000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8152000000,
              "concept": "AccountsReceivableNetCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3788000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 6156000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8917000000,
              "concept": "OtherLiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 79162000000,
              "concept": "StockholdersEquityBeforeTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -3126000000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 39950000000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 40550000000,
              "concept": "AdditionalPaidInCapitalCommonStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1788000000,
              "concept": "CommonStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 15883000000,
              "concept": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 105525000000,
              "concept": "LiabilitiesAndStockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 55194000000,
              "concept": "StockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "Marketable Securities, Noncurrent",
              "value": 4085000000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 15867000000,
              "concept": "PropertyPlantAndEquipmentNet"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "",
              "value": 3587000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 122000000,
              "concept": "EquityMethodInvestmentDividendsOrDistributions"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Tax Expense (Benefit)",
              "value": -365000000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 169000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "Proceeds from Sale, Maturity and Collection of Investments",
              "value": 4174000000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -568000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Proceeds from Stock Options Exercised",
              "value": 601000000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -3000000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -1311000000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 26000000,
              "concept": "EffectOfExchangeRateOnCashAndCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3221000000,
              "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3594000000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1637000000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebt"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5074000000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 762000000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Asset Impairment Charges",
              "value": 136000000,
              "concept": "AssetImpairmentCharges"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -143000000,
              "concept": "OtherNoncashIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2059000000,
              "concept": "IncreaseDecreaseInOperatingCapital"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 4001000000,
              "concept": "PaymentsToAcquireMarketableSecurities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -21000000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 253000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2000000,
              "concept": "RepaymentsOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 985000000,
              "concept": "PaymentsForRepurchaseOfCommonStock"
            },
            {
              "unit": "usd",
              "label": "Payments of Dividends, Common Stock",
              "value": 2559000000,
              "concept": "PaymentsOfDividendsCommonStock"
            }
          ],
          "ic": [
            {
              "unit": "usd/shares",
              "label": "",
              "value": 1.16,
              "concept": "EarningsPerShareBasic"
            },
            {
              "unit": "usd/shares",
              "label": "",
              "value": 1.15,
              "concept": "EarningsPerShareDiluted"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3531000000,
              "concept": "NetIncomeLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 56000000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3587000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1599000000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5186000000,
              "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 24041000000,
              "concept": "SalesRevenueGoodsNet"
            },
            {
              "unit": "usd/shares",
              "label": "",
              "value": 0.84,
              "concept": "CommonStockDividendsPerShareDeclared"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8150000000,
              "concept": "CostOfGoodsSold"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 6322000000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 4026000000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 363000000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 253000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Costs Expenses And Other",
              "value": 18855000000,
              "concept": "mrk:CostsExpensesAndOther"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -247000000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3537000000,
              "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 6000000,
              "concept": "OtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -86000000,
              "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 44000000,
              "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -18000000,
              "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 30000000,
              "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"
            }
          ]
        }
      },
      {
        "accessNumber": "0001193125-12-216683",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2012,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2012-01-01 00:00:00",
        "endDate": "2012-03-31 00:00:00",
        "filedDate": "2012-05-08 00:00:00",
        "acceptedDate": "2012-05-08 07:40:16",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "",
              "value": 14656000000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 910000000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventory, Net",
              "value": 6339000000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 12156000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 33000000000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 105509000000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Debt, Current",
              "value": 2930000000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2358000000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1190000000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1281000000,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 15228000000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 23804000000,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2454000000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 57314000000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16582000000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 34344000000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8726000000,
              "concept": "AccountsReceivableNetCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3713000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5913000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8823000000,
              "concept": "OtherLiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 78664000000,
              "concept": "StockholdersEquityBeforeTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -3217000000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 39441000000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 40652000000,
              "concept": "AdditionalPaidInCapitalCommonStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1788000000,
              "concept": "CommonStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16385000000,
              "concept": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 105509000000,
              "concept": "LiabilitiesAndStockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 54860000000,
              "concept": "StockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "Marketable Securities, Noncurrent",
              "value": 3972000000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16124000000,
              "concept": "PropertyPlantAndEquipmentNet"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "",
              "value": 1767000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 110000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 66000000,
              "concept": "EquityMethodInvestmentDividendsOrDistributions"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Tax Expense (Benefit)",
              "value": -41000000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 76000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -71000000,
              "concept": "OtherNoncashIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 331000000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Proceeds from Sale, Maturity and Collection of Investments",
              "value": 2797000000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 11000000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -270000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1279000000,
              "concept": "PaymentsOfDividendsCommonStock"
            },
            {
              "unit": "usd",
              "label": "Proceeds from Stock Options Exercised",
              "value": 379000000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -3000000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -725000000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -34000000,
              "concept": "EffectOfExchangeRateOnCashAndCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1125000000,
              "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1790000000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 456000000,
              "concept": "PaymentsForRepurchaseOfCommonStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2725000000,
              "concept": "PaymentsToAcquireMarketableSecurities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 634000000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebt"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2154000000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1474000000,
              "concept": "IncreaseDecreaseInOperatingCapital"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 9000000,
              "concept": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"
            }
          ],
          "ic": [
            {
              "unit": "usd/shares",
              "label": "",
              "value": 0.57,
              "concept": "EarningsPerShareBasic"
            },
            {
              "unit": "usd/shares",
              "label": "",
              "value": 0.56,
              "concept": "EarningsPerShareDiluted"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1738000000,
              "concept": "NetIncomeLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 29000000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1767000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 740000000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2507000000,
              "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 11731000000,
              "concept": "SalesRevenueGoodsNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -142000000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 110000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 219000000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1862000000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3074000000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 4037000000,
              "concept": "CostOfGoodsSold"
            },
            {
              "unit": "usd",
              "label": "Costs Expenses And Other",
              "value": 9224000000,
              "concept": "mrk:CostsExpensesAndOther"
            },
            {
              "unit": "usd/shares",
              "label": "",
              "value": 0.42,
              "concept": "CommonStockDividendsPerShareDeclared"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1653000000,
              "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -85000000,
              "concept": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -56000000,
              "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 29000000,
              "concept": "OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
              "value": -58000000,
              "concept": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease"
            }
          ]
        }
      },
      {
        "accessNumber": "0000950123-11-096564",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2011,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2011-01-01 00:00:00",
        "endDate": "2011-09-30 00:00:00",
        "filedDate": "2011-11-08 00:00:00",
        "acceptedDate": "2011-11-08 17:12:56",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "",
              "value": 14253000000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1323000000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventory, Net",
              "value": 6239000000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 12228000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 35822000000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 106534000000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Debt, Current",
              "value": 2455000000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2282000000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1462000000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1166000000,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 15692000000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 23415000000,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2456000000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 57596000000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16383000000,
              "concept": "PropertyPlantAndEquipmentNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16593000000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 34109000000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Marketable Securities, Noncurrent",
              "value": 2423000000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8136000000,
              "concept": "AccountsReceivableNetCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 4158000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5569000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 9228000000,
              "concept": "OtherLiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 78555000000,
              "concept": "StockholdersEquityBeforeTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -2713000000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 38763000000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 40717000000,
              "concept": "AdditionalPaidInCapitalCommonStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1788000000,
              "concept": "CommonStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16653000000,
              "concept": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 106534000000,
              "concept": "LiabilitiesAndStockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 55140000000,
              "concept": "StockholdersEquity"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "",
              "value": 4849000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 354000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 186000000,
              "concept": "EquityMethodInvestmentDividendsOrDistributions"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Tax Expense (Benefit)",
              "value": -974000000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 287000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 207000000,
              "concept": "OtherNoncashIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1120000000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 4740000000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 373000000,
              "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 90000000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -1206000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1277000000,
              "concept": "RepaymentsOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3526000000,
              "concept": "PaymentsOfDividendsCommonStock"
            },
            {
              "unit": "usd",
              "label": "Proceeds from Stock Options Exercised",
              "value": 194000000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -61000000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -4673000000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 82000000,
              "concept": "EffectOfExchangeRateOnCashAndCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3353000000,
              "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 9150000000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5566000000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 664000000,
              "concept": "IncreaseDecreaseInOperatingCapital"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 323000000,
              "concept": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 461000000,
              "concept": "AssetImpairmentCharges"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1359000000,
              "concept": "PaymentsForRepurchaseOfCommonStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 4686000000,
              "concept": "PaymentsToAcquireMarketableSecurities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1356000000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebt"
            }
          ],
          "ic": [
            {
              "unit": "usd/shares",
              "label": "",
              "value": 1.54,
              "concept": "EarningsPerShareBasic"
            },
            {
              "unit": "usd/shares",
              "label": "",
              "value": 1.53,
              "concept": "EarningsPerShareDiluted"
            },
            {
              "unit": "usd/shares",
              "label": "",
              "value": 1.14,
              "concept": "CommonStockDividendsPerShareDeclared"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 4760000000,
              "concept": "NetIncomeLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 89000000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 4849000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 904000000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5753000000,
              "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 35753000000,
              "concept": "SalesRevenueGoodsNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -809000000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 354000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 773000000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 6048000000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 10029000000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 12695000000,
              "concept": "CostOfGoodsSold"
            },
            {
              "unit": "usd",
              "label": "Costs Expenses And Other",
              "value": 30000000000,
              "concept": "mrk:CostsExpensesAndOther"
            }
          ]
        }
      },
      {
        "accessNumber": "0000950123-11-074096",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2011,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2011-01-01 00:00:00",
        "endDate": "2011-06-30 00:00:00",
        "filedDate": "2011-08-08 00:00:00",
        "acceptedDate": "2011-08-08 07:43:43",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2143000000.0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts Receivable, Net, Current",
              "value": 8475000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1174000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
              "value": -2776000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Additional Paid in Capital, Common Stock",
              "value": 40657000000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 106195000000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 32368000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 12342000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,576,948,356 shares in 2011 and 2010",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Debt, Current",
              "value": 2523000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes and Other Assets, Current",
              "value": 3687000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes and Other Assets, Noncurrent",
              "value": 5534000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes and Other Liabilities, Noncurrent",
              "value": 16727000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends Payable, Current",
              "value": 1176000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12382000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible Assets, Net (Excluding Goodwill)",
              "value": 37065000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventory, Net",
              "value": 6225000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Liabilities and Stockholders' Equity",
              "value": 106195000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 15763000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long Term Debt Noncurrent",
              "value": 15783000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 1639000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Marketable Securities, Noncurrent",
              "value": 2175000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Minority Interest",
              "value": 2426000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Other Liabilities, Current",
              "value": 8747000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net",
              "value": 16671000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 38243000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Stockholders Equity",
              "value": 55496000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' Equity before Treasury Stock",
              "value": 77912000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
              "value": 57922000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Treasury Stock, Value",
              "value": 22416000000.0
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Costs Expenses And Other",
              "value": 20331000000.0
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usdeps",
              "label": "Common Stock, Dividends, Per Share, Declared",
              "value": 0.76
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Cost of Goods Sold",
              "value": 8343000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usdeps",
              "label": "Earnings Per Share, Basic",
              "value": 0.99
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usdeps",
              "label": "Earnings Per Share, Diluted",
              "value": 0.98
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest",
              "value": 3401000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 193000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income Tax Expense (Benefit)",
              "value": 276000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Loss",
              "value": 3067000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
              "value": 58000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other Nonoperating Income (Expense)",
              "value": -744000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Profit Loss",
              "value": 3125000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and Development Expense",
              "value": 4094000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring Charges",
              "value": 654000000.0
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales Revenue, Goods, Net",
              "value": 23732000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, General and Administrative Expense",
              "value": 6689000000.0
            }
          ],
          "cf": [
            {
              "concept": "mrk_GainRecognizedUponPartnerAssetOptionExercise",
              "unit": "usd",
              "label": "Gain Recognized Upon Partner Asset Option Exercise",
              "value": 0.0
            },
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 439000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
              "value": 1442000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred Income Tax Expense (Benefit)",
              "value": -841000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation, Depletion and Amortization",
              "value": 3663000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
              "value": 241000000.0
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 121000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 193000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Increase (Decrease) in Operating Capital",
              "value": 1485000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Financing Activities",
              "value": -2429000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Investing Activities",
              "value": -943000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 4573000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other Noncash Income Expense",
              "value": 456000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Payments for (Proceeds from) Other Investing Activities",
              "value": 28000000.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Payments for Repurchase of Common Stock",
              "value": 314000000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2351000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 373000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Payments to Acquire Marketable Securities",
              "value": 3066000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 689000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
              "value": 323000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Proceeds from (Payments for) Other Financing Activities",
              "value": -57000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Proceeds from (Repayments of) Short-term Debt",
              "value": 1396000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 2890000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from Stock Options Exercised",
              "value": 162000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Profit Loss",
              "value": 3125000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1265000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share Based Compensation",
              "value": 200000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000950123-11-047041",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2011,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2011-01-01 00:00:00",
        "endDate": "2011-03-31 00:00:00",
        "filedDate": "2011-05-09 00:00:00",
        "acceptedDate": "2011-05-09 07:58:35",
        "report": {
          "bs": [
            {
              "concept": "mrk_AccruedAndOtherCurrentLiabilities",
              "unit": "usd",
              "label": "Accrued And Other Current Liabilities",
              "value": 8555000000.0
            },
            {
              "concept": "mrk_DeferredTaxesAndNoncurrentLiabilities",
              "unit": "usd",
              "label": "Deferred Taxes And Noncurrent Liabilities",
              "value": 17720000000.0
            },
            {
              "concept": "mrk_StockholdersEquityBeforeDeductionForTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' Equity Before Deduction For Treasury Stock",
              "value": 76708000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2402000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1326000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
              "value": -3170000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Additional Paid in Capital, Common Stock",
              "value": 40690000000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 105865000000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 31024000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Period",
              "value": 11695000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,576,948,356 shares in 2011 and 2010",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Debt, Current",
              "value": 2202000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends Payable, Current",
              "value": 1177000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12207000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 37906000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,264 in 2011 and $1,194 in 2010 classified in Other assets - see Note 6)",
              "value": 6057000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Stockholders' Equity",
              "value": 105865000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 15662000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 15644000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 1334000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 2084000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Minority Interest",
              "value": 2455000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 3983000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5811000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net",
              "value": 16833000000.0
            },
            {
              "concept": "us-gaap_ReceivablesNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $111 in 2011 and $104 in 2010)",
              "value": 7955000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 37400000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Stockholders Equity",
              "value": 54384000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
              "value": 56839000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 491,657,062 shares in 2011 and 494,841,533 shares in 2010",
              "value": 22324000000.0
            }
          ],
          "ic": [
            {
              "concept": "mrk_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterests",
              "unit": "usd",
              "label": "Income Loss From Continuing Operations Before Income Taxes Minority Interests",
              "value": 1729000000.0
            },
            {
              "concept": "mrk_TotalCostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs Expenses And Other",
              "value": 9851000000.0
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usdeps",
              "label": "Common Stock, Dividends, Per Share, Declared",
              "value": 0.38
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Cost of Goods Sold",
              "value": 4059000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usdeps",
              "label": "Earnings Per Share, Basic",
              "value": 0.34
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usdeps",
              "label": "Earnings Per Share, Diluted",
              "value": 0.34
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 138000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income Tax Expense (Benefit)",
              "value": 658000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Loss",
              "value": 1043000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
              "value": 28000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other Nonoperating Income (Expense)",
              "value": -622000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Profit Loss",
              "value": 1071000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and Development Expense",
              "value": 2158000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": -14000000.0
            },
            {
              "concept": "us-gaap_SalesRevenueNet",
              "unit": "usd",
              "label": "Sales Revenue, Net",
              "value": 11580000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, General and Administrative Expense",
              "value": 3164000000.0
            }
          ],
          "cf": [
            {
              "concept": "mrk_PurchasesSecuritiesAndOtherInvestments",
              "unit": "usd",
              "label": "Purchases Securities And Other Investments",
              "value": 1382000000.0
            },
            {
              "concept": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther",
              "unit": "usd",
              "label": "Other",
              "value": -222000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
              "value": 795000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred Income Tax Expense (Benefit)",
              "value": -214000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation, Depletion and Amortization",
              "value": 1831000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 141000000.0
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 65000000.0
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
              "unit": "usd",
              "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
              "value": 302000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 138000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Increase (Decrease) in Operating Capital",
              "value": 1067000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities",
              "value": -1172000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Investing Activities",
              "value": 105000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 1721000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 19000000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1175000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 324000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
              "value": 306000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 167000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -197000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1524000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from Stock Options Exercised",
              "value": 37000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Profit Loss",
              "value": 1071000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 4000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share Based Compensation",
              "value": 93000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000950123-10-102135",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2010,
        "quarter": 3,
        "form": "10-Q",
        "startDate": "2010-01-01 00:00:00",
        "endDate": "2010-09-30 00:00:00",
        "filedDate": "2010-11-08 00:00:00",
        "acceptedDate": "2010-11-08 07:47:43",
        "report": {
          "bs": [
            {
              "concept": "mrk_AccruedAndOtherCurrentLiabilities",
              "unit": "usd",
              "label": "Accrued And Other Current Liabilities",
              "value": 8159500000.0
            },
            {
              "concept": "mrk_DeferredTaxesAndNoncurrentLiabilities",
              "unit": "usd",
              "label": "Deferred Taxes And Noncurrent Liabilities",
              "value": 18436600000.0
            },
            {
              "concept": "mrk_SixPercentMandatoryConvertiblePreferredStock",
              "unit": "usd",
              "label": "Six Percent Mandatory convertible preferred stock",
              "value": 0.0
            },
            {
              "concept": "mrk_StockholdersEquityBeforeDeductionForTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' Equity Before Deduction For Treasury Stock",
              "value": 78100600000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2242400000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1629700000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
              "value": -3490000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Additional Paid in Capital, Common Stock",
              "value": 40556700000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 107840100000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 27756000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents, at Carrying Value",
              "value": 9874400000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common Stock Value",
              "value": 1788500000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 4116000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends Payable, Current",
              "value": 1175700000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12480800000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 42954400000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventory, Net",
              "value": 6263600000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Stockholders' Equity",
              "value": 107840100000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 17323300000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 14031900000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 750400000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 2137500000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Minority Interest",
              "value": 2455500000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 3570100000.0
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5395600000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net",
              "value": 17115800000.0
            },
            {
              "concept": "us-gaap_ReceivablesNetCurrent",
              "unit": "usd",
              "label": "Receivables, Net, Current",
              "value": 7297500000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 39245400000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Stockholders Equity",
              "value": 55592800000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Ending balance",
              "value": 58048300000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Treasury Stock, Value",
              "value": 22507800000.0
            }
          ],
          "ic": [
            {
              "concept": "mrk_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterests",
              "unit": "usd",
              "label": "Income Loss From Continuing Operations Before Income Taxes Minority Interests",
              "value": 2354200000.0
            },
            {
              "concept": "mrk_TotalCostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs Expenses And Other",
              "value": 31539100000.0
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usdeps",
              "label": "Common Stock, Dividends, Per Share, Declared",
              "value": 1.14
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 13955900000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usdeps",
              "label": "Earnings Per Share, Basic",
              "value": 0.45
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usdeps",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders",
              "value": 0.44
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 416800000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 872200000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Loss",
              "value": 1392700000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
              "value": 89300000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other Nonoperating Income (Expense)",
              "value": -995600000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1482000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and Development Expense",
              "value": 6474000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring Charges",
              "value": 863600000.0
            },
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Revenues",
              "value": 33893300000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, General and Administrative Expense",
              "value": 9666800000.0
            }
          ],
          "cf": [
            {
              "concept": "mrk_GainRecognizedUponJoinVenturePartnerAssetOptionExercise",
              "unit": "usd",
              "label": "Gain Recognized Upon Join Venture Partner Asset Option Exercise",
              "value": 443000000.0
            },
            {
              "concept": "mrk_IncreaseDecreaseInRestrictedCashInvestments",
              "unit": "usd",
              "label": "Increase Decrease In Restricted Cash Investments",
              "value": -6800000.0
            },
            {
              "concept": "mrk_PurchasesSecuritiesAndOtherInvestments",
              "unit": "usd",
              "label": "Purchases Securities And Other Investments",
              "value": 5826100000.0
            },
            {
              "concept": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther",
              "unit": "usd",
              "label": "Other",
              "value": 443600000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase in Cash and Cash Equivalents",
              "value": 563000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -742800000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation, Depletion and Amortization",
              "value": 5515000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -84300000.0
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 263800000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 416800000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Increase (Decrease) in Operating Capital",
              "value": -781600000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities",
              "value": -4146100000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -2489500000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 7282900000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -139600000.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Payments for Repurchase of Common Stock",
              "value": 1593300000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3559200000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 151800000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1017700000.0
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture",
              "unit": "usd",
              "label": "Proceeds from Divestiture of Interest in Joint Venture",
              "value": 647000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds From Issuance Of Long Term Debt",
              "value": 5300000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -195500000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 1573000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 3726300000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 312900000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 1482000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 689300000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 399500000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000950123-10-074336",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2010,
        "quarter": 2,
        "form": "10-Q",
        "startDate": "2010-01-01 00:00:00",
        "endDate": "2010-06-30 00:00:00",
        "filedDate": "2010-08-06 00:00:00",
        "acceptedDate": "2010-08-06 16:24:30",
        "report": {
          "bs": [
            {
              "concept": "mrk_AccruedAndOtherCurrentLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 6834400000.0
            },
            {
              "concept": "mrk_DeferredTaxesAndNoncurrentLiabilities",
              "unit": "usd",
              "label": "Deferred Income Taxes and Noncurrent Liabilities",
              "value": 19248900000.0
            },
            {
              "concept": "mrk_SixPercentMandatoryConvertiblePreferredStock",
              "unit": "usd",
              "label": "Six Percent Mandatory convertible preferred stock",
              "value": 206000000.0
            },
            {
              "concept": "mrk_StockholdersEquityBeforeDeductionForTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 77547300000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2171500000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 879400000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated ending balances",
              "value": -4658700000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Additional Paid in Capital, Common Stock",
              "value": 40337700000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 106170500000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 26253600000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents, at Carrying Value",
              "value": 8665600000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value, Authorized - 6,500,000,000 shares Issued - 3,572,963,192 shares in 2010; 3,562,528,536 shares in 2009",
              "value": 1786500000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 4147300000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1182000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12225500000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 43281400000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventory, Net",
              "value": 6244200000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Stockholders' Equity",
              "value": 106170500000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 15420600000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 13835300000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 1277000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 2045600000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling interests, beginning balance",
              "value": 2434000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 3790700000.0
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5030200000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net",
              "value": 17334200000.0
            },
            {
              "concept": "us-gaap_ReceivablesNetCurrent",
              "unit": "usd",
              "label": "Receivables, Net, Current",
              "value": 6276100000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 40081800000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Stockholders' Equity Attributable to Parent",
              "value": 55231700000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Ending balance",
              "value": 57665700000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Treasury Stock, Value",
              "value": 22315600000.0
            }
          ],
          "ic": [
            {
              "concept": "mrk_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterests",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 1856600000.0
            },
            {
              "concept": "mrk_TotalCostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 20911900000.0
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usdeps",
              "label": "Common Stock, Dividends, Per Share, Declared",
              "value": 0.76
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 9764500000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usdeps",
              "label": "Earnings Per Share, Basic",
              "value": 0.34
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usdeps",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders",
              "value": 0.33
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 180400000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 746200000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net income attributable to Merck & Co., Inc.",
              "value": 1051200000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
              "value": 59200000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other Nonoperating Income (Expense)",
              "value": 112700000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income attributable to Merck & Co., Inc.",
              "value": 1110400000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and Development Expense",
              "value": 4177600000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring Charges",
              "value": 814000000.0
            },
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Revenues",
              "value": 22768500000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 6448900000.0
            }
          ],
          "cf": [
            {
              "concept": "mrk_GainRecognizedUponJoinVenturePartnerAssetOptionExercise",
              "unit": "usd",
              "label": "Gain recognized upon AstraZenecas asset option exercise.",
              "value": 443000000.0
            },
            {
              "concept": "mrk_IncreaseDecreaseInRestrictedCashInvestments",
              "unit": "usd",
              "label": "Increase Decrease In Restricted Cash Investments",
              "value": -7000000.0
            },
            {
              "concept": "mrk_PurchasesSecuritiesAndOtherInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 4235200000.0
            },
            {
              "concept": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther",
              "unit": "usd",
              "label": "Other",
              "value": 437000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
              "value": -645800000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -318900000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation, Depletion and Amortization",
              "value": 3635100000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -131400000.0
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 182100000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 180400000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOperatingCapital",
              "unit": "usd",
              "label": "Increase (Decrease) in Operating Capital",
              "value": 5500000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities",
              "value": -2521100000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -2684300000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 4691000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -32400000.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Payments for Repurchase of Common Stock",
              "value": 1297200000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 2377900000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 141300000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 679800000.0
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture",
              "unit": "usd",
              "label": "Proceeds from Divestiture of Interest in Joint Venture",
              "value": 647000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from Issuance of Long-term Debt",
              "value": 5300000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -120100000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 1657700000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1699600000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 237200000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income attributable to Merck & Co., Inc.",
              "value": 1110400000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 626100000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 274200000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000950123-10-045997",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2010,
        "quarter": 1,
        "form": "10-Q",
        "startDate": "2010-01-01 00:00:00",
        "endDate": "2010-03-31 00:00:00",
        "filedDate": "2010-05-07 00:00:00",
        "acceptedDate": "2010-05-07 08:20:51",
        "report": {
          "bs": [
            {
              "concept": "mrk_AccruedAndOtherCurrentLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 8439000000.0
            },
            {
              "concept": "mrk_DeferredIncomeTaxesAndNoncurrentLiabilities",
              "unit": "usd",
              "label": "Deferred Income Taxes and Noncurrent Liabilities",
              "value": 19514200000.0
            },
            {
              "concept": "mrk_SixPercentMandatoryConvertiblePreferredStock",
              "unit": "usd",
              "label": "Six Percent Mandatory Convertible Preferred Stock",
              "value": 206200000.0
            },
            {
              "concept": "mrk_StockholdersEquityBeforeDeductionForTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 78922400000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2074900000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 723000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -3571600000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40196600000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 111593800000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 28244900000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8236000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common Stock, Value, Issued",
              "value": 1786000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3822400000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends Payable, Current",
              "value": 1189800000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12266200000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 45574900000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventory, Net",
              "value": 6825400000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Stockholders' Equity",
              "value": 111593800000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 16455300000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 15281100000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 1541300000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 1995000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 2465100000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 4144500000.0
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5527800000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net",
              "value": 17985000000.0
            },
            {
              "concept": "us-gaap_ReceivablesNetCurrent",
              "unit": "usd",
              "label": "Receivables, Net, Current",
              "value": 7497700000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 40511400000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders' equity",
              "value": 57878100000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
              "value": 60343200000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Treasury Stock, Value",
              "value": 21044300000.0
            }
          ],
          "ic": [
            {
              "concept": "mrk_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterests",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 615800000.0
            },
            {
              "concept": "mrk_TotalCostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 10806400000.0
            },
            {
              "concept": "us-gaap_CommonStockDividendsPerShareDeclared",
              "unit": "usdeps",
              "label": "Dividends Declared per Common Share",
              "value": 0.38
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 5215600000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usdeps",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders",
              "value": 0.1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usdeps",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders",
              "value": 0.09
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 137500000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 285600000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 298800000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 31400000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -167700000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 330200000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 2026700000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 287700000.0
            },
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 11422200000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 3246200000.0
            }
          ],
          "cf": [
            {
              "concept": "mrk_IncreaseDecreaseInRestrictedCashInvestments",
              "unit": "usd",
              "label": "Increase Decrease In Restricted Cash Investments",
              "value": -25100000.0
            },
            {
              "concept": "mrk_PurchasesSecuritiesAndOtherInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 2932700000.0
            },
            {
              "concept": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther",
              "unit": "usd",
              "label": "Other",
              "value": 188000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
              "value": -1075400000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 152200000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 1687400000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -235600000.0
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 77400000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 137500000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Net changes in assets and liabilities",
              "value": -1064000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used by) Financing Activities",
              "value": 942200000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Investing Activities",
              "value": -3148100000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 1366100000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -11100000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 1188600000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions of subsidiaries, net of cash acquired",
              "value": 131300000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 342800000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -62600000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 2620400000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 272700000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 195300000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 330200000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 622300000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 132400000.0
            }
          ]
        }
      }
    ],
    "symbol": "MRK"
  }
}